☰

Brian E. Leonard - Publications

Affiliations: 
University College Galway, Galway, County Galway, Ireland 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

165/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cowan C, Leonard BE. Preface. Modern Trends in Psychiatry. 32: VIII-IX. PMID 34032651 DOI: 10.1159/000511097  0.727
2019 Leonard BE, Wegener G. Inflammation, insulin resistance and neuroprogression in depression. Acta Neuropsychiatrica. 1-9. PMID 31186075 DOI: 10.1017/neu.2019.17  0.319
2019 Demin KA, Sysoev M, Chernysh MV, Savva AK, Koshiba M, Wappler-Guzzetta EA, Song C, De Abreu MS, Leonard B, Parker MO, Harvey BH, Tian L, Vasar E, Strekalova T, Amstislavskaya TG, et al. Animal models of major depressive disorder and the implications for drug discovery and development. Expert Opinion On Drug Discovery. 1-14. PMID 30793996 DOI: 10.1080/17460441.2019.1575360  0.315
2017 Ma L, Demin KA, Kolesnikova TO, Kharsko SL, Zhu X, Yuan X, Song C, Meshalkina DA, Leonard BE, Tian L, Kalueff AV. Animal inflammation-based models of depression and their application to drug discovery. Expert Opinion On Drug Discovery. 1-15. PMID 28816544 DOI: 10.1080/17460441.2017.1362385  0.332
2015 Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 26111720 DOI: 10.1016/j.pnpbp.2015.06.008  0.318
2014 Leonard BE. Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48: 261-7. PMID 24189118 DOI: 10.1016/j.pnpbp.2013.10.018  0.338
2012 Maes M, Berk M, Goehler L, Song C, Anderson G, GaÅ‚ecki P, Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. Bmc Medicine. 10: 66. PMID 22747645 DOI: 10.1186/1741-7015-10-66  0.31
2012 Montgomery SA, Bebbington P, Cowen P, Deakin W, Freeling P, Hallstrom C, Katona C, King D, Leonard B, Levine S, Phanjoo A, Peet M, Thompson C. Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology (Oxford, England). 7: 19-23. PMID 22290366 DOI: 10.1177/0269881193007001041  0.321
2012 Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neuroscience and Biobehavioral Reviews. 36: 764-785. PMID 22197082 DOI: 10.1016/j.neubiorev.2011.12.005  0.335
2012 Tang SW, Helmeste D, Leonard B. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review World Journal of Biological Psychiatry. 13: 402-412. PMID 22175526 DOI: 10.3109/15622975.2011.639800  0.327
2011 Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 702-21. PMID 21185346 DOI: 10.1016/j.pnpbp.2010.12.017  0.344
2010 Leonard BE. The concept of depression as a dysfunction of the immune system. Current Immunology Reviews. 6: 205-212. PMID 21170282 DOI: 10.2174/157339510791823835  0.36
2010 Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. The British Journal of Psychiatry : the Journal of Mental Science. 197: 372-7. PMID 21037214 DOI: 10.1192/Bjp.Bp.109.076430  0.318
2010 Leonard B, Taylor D. Review: Escitalopram-translating molecular properties into clinical benefit: Reviewing the evidence in major depression Journal of Psychopharmacology. 24: 1143-1152. PMID 20147575 DOI: 10.1177/0269881109349835  0.317
2010 Cryan JF, Leonard BE. Depression: From psychopathology to pharmacotherapy Depression: From Psychopathology to Pharmacotherapy. 27: 1-274. DOI: 10.1159/isbn.978-3-8055-9606-0  0.365
2009 Leonard BE, Myint A. The psychoneuroimmunology of depression. Human Psychopharmacology. 24: 165-75. PMID 19212943 DOI: 10.1002/hup.1011  0.338
2009 Myint AM, Schwarz MJ, Steinbusch HW, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease. 24: 55-68. PMID 19067144 DOI: 10.1007/s11011-008-9114-5  0.328
2007 Leonard BE. Psychopathology of depression. Drugs of Today (Barcelona, Spain : 1998). 43: 705-16. PMID 17987223 DOI: 10.1358/dot.2007.43.10.1122223  0.324
2007 Myint AM, O'Mahony S, Kubera M, Kim YK, Kenny C, Kaim-Basta A, Steinbusch HW, Leonard BE. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. Journal of Psychopharmacology (Oxford, England). 21: 843-50. PMID 17984161 DOI: 10.1177/0269881107077165  0.582
2007 Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation. 14: 65-71. PMID 17713352 DOI: 10.1159/000107420  0.347
2007 Leonard BE. Inflammation, depression and dementia: are they connected? Neurochemical Research. 32: 1749-56. PMID 17705097 DOI: 10.1007/s11064-007-9385-y  0.317
2007 Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. Journal of Affective Disorders. 98: 143-51. PMID 16952400 DOI: 10.1016/j.jad.2006.07.013  0.324
2006 Leonard BE. HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation. 13: 268-76. PMID 17709948 DOI: 10.1159/000104854  0.336
2006 Leonard BE, Myint A. Inflammation and depression: is there a causal connection with dementia? Neurotoxicity Research. 10: 149-60. PMID 17062376 DOI: 10.1007/BF03033243  0.323
2006 O'Mahony SM, Myint AM, van den Hove D, Desbonnet L, Steinbusch H, Leonard BE. Gestational stress leads to depressive-like behavioural and immunological changes in the rat. Neuroimmunomodulation. 13: 82-8. PMID 17033197 DOI: 10.1159/000096090  0.572
2006 Myint AM, Goeghegan L, Luchtman D, Steinbusch HWM, Leonard BE. P.2.d.014 Effect of the selective COX-2 inhibitor, celecoxib, on brain cytokines in the olfactory bulbectomised rat model of depression European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70385-6  0.334
2005 O'Mahony SM, Myint AM, Steinbusch H, Leonard BE. Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats. Neuroimmunomodulation. 12: 293-8. PMID 16166808 DOI: 10.1159/000087107  0.59
2005 Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews. 29: 627-47. PMID 15925697 DOI: 10.1016/j.neubiorev.2005.03.010  0.336
2003 Harkin A, Kelly JP, Leonard BE. A review of the relevance and validity of olfactory bulbectomy as a model of depression Clinical Neuroscience Research. 3: 253-262. DOI: 10.1016/S1566-2772(03)00087-2  0.333
2002 Leonard BE. Stress, norepinephrine and depression. Acta Neuropsychiatrica. 14: 173-80. PMID 26984329 DOI: 10.1034/j.1601-5215.2002.140403.x  0.344
2002 Leonard BE, Song C. Changes in the immune system in rodent models of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 345-56. PMID 12466034 DOI: 10.1017/S1461145702003140  0.348
2002 Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain, Behavior, and Immunity. 16: 569-74. PMID 12401470 DOI: 10.1016/S0889-1591(02)00008-9  0.354
2002 Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 461-75. PMID 12208564 DOI: 10.1016/S0924-977X(02)00057-3  0.329
2001 Harkany T, O'Mahony S, Keijser J, Kelly JP, Kónya C, Borostyánkoi ZA, Görcs TJ, Zarándi M, Penke B, Leonard BE, Luiten PG. Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiology of Disease. 8: 667-78. PMID 11493031 DOI: 10.1006/Nbdi.2001.0398  0.537
2001 Harkin A, Connor TJ, Mulrooney J, Kelly JP, Leonard BE. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sciences. 68: 1367-82. PMID 11388689 DOI: 10.1016/S0024-3205(00)01039-0  0.575
2001 Leonard BE. The immune system, depression and the action of antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 767-80. PMID 11383977 DOI: 10.1016/S0278-5846(01)00155-5  0.343
2001 Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects? International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 19: 305-12. PMID 11337199 DOI: 10.1016/S0736-5748(01)00014-4  0.337
2001 Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE. Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology. 154: 177-88. PMID 11314680 DOI: 10.1007/S002130000630  0.3
2001 Ryan PM, Kelly JP, Chambers PL, Leonard BE. The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat. Pharmacology & Toxicology. 88: 59-66. PMID 11169163 DOI: 10.1034/J.1600-0773.2001.D01-84.X  0.312
2000 Leonard B. Stress, depression and the activation of the immune system. World Journal of Biological Psychiatry. 1: 17-25. PMID 12607229 DOI: 10.3109/15622970009150562  0.326
2000 Cryan JF, Leonard BE. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Human Psychopharmacology. 15: 113-135. PMID 12404340 DOI: 10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W  0.448
2000 Nolan Y, Connor TJ, Kelly JP, Leonard BE. Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1393-401. PMID 11458992 DOI: 10.1007/s007020070003  0.547
2000 Harkin A, Nally R, Kelly JP, Leonard BE. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1213-27. PMID 11129111 DOI: 10.1016/S0924-977X(00)80279-5  0.329
2000 Feighner JP, Ehrensing RH, Kastin AJ, Leonard BE, Sverdlov L, Nicolau G, Patel A, Hlavka J, Abajian H, Noble JF. A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression. Journal of Affective Disorders. 61: 119-26. PMID 11099750 DOI: 10.1016/S0165-0327(99)00187-1  0.324
2000 Connor TJ, Kelly JP, McGee M, Leonard BE. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sciences. 67: 1601-12. PMID 10983854 DOI: 10.1016/S0024-3205(00)00743-8  0.52
2000 Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiology & Behavior. 69: 531-9. PMID 10913793 DOI: 10.1016/S0031-9384(00)00213-4  0.552
2000 Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, Biochemistry, and Behavior. 65: 591-7. PMID 10764911 DOI: 10.1016/S0091-3057(99)00192-6  0.579
2000 Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology. 46: 223-35. PMID 10741902 DOI: 10.1016/S0162-3109(99)00180-0  0.548
2000 Wrynn AS, Sebens JB, Koch T, Leonard BE, Korf J. Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset. Brain Research. Molecular Brain Research. 76: 7-17. PMID 10719210 DOI: 10.1016/S0169-328X(99)00326-5  0.309
2000 Cryan JF, Harkin A, Naughton M, Kelly JP, Leonard BE. Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. European Journal of Pharmacology. 390: 275-85. PMID 10708734 DOI: 10.1016/S0014-2999(00)00012-1  0.452
2000 Connor TJ, Harkin A, Kelly JP, Leonard BE. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment. Neuroimmunomodulation. 7: 27-35. PMID 10601816 DOI: 10.1159/000026417  0.575
2000 Kelly JP, Connor TJ, Nolan Y, Shen Y, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms and the pro-/anti-inflammatory cytokine balance European Neuropsychopharmacology. 10: 278-279. DOI: 10.1016/S0924-977X(00)80278-3  0.555
1999 Dredge K, Connor TJ, Kelly JP, Leonard BE. Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. International Journal of Immunopharmacology. 21: 663-73. PMID 12609461 DOI: 10.1016/S0192-0561(99)00042-9  0.558
1999 Kelly JP, Nicolau G, Redmond A, Leonard BE, Noble J, Sverdlov L, Molinar R, Kastin AJ, Ehrensing RH, Feighner JP. The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. Journal of Affective Disorders. 55: 231-5. PMID 10628893 DOI: 10.1016/S0165-0327(99)00018-X  0.316
1999 Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sciences. 65: 1773-86. PMID 10576557 DOI: 10.1016/S0024-3205(99)00430-0  0.578
1999 Cryan JF, Kelliher P, Kelly JP, Leonard BE. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. Journal of Psychopharmacology (Oxford, England). 13: 278-83. PMID 10512084 DOI: 10.1177/026988119901300310  0.349
1999 Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. European Journal of Pharmacology. 379: 125-33. PMID 10497898 DOI: 10.1016/S0014-2999(99)00492-6  0.568
1999 Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology. 145: 303-8. PMID 10494579 DOI: 10.1007/S002130051062  0.518
1999 Cryan JF, McGrath C, Leonard BE, Norman TR. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacology, Biochemistry, and Behavior. 63: 333-8. PMID 10371664 DOI: 10.1016/S0091-3057(98)00245-7  0.491
1999 Connor TJ, Song C, Leonard BE, Anisman H, Merali Z. Stressor-induced alterations in serotonergic activity in an animal model of depression. Neuroreport. 10: 523-8. PMID 10208583 DOI: 10.1097/00001756-199902250-00015  0.587
1999 Redmond AM, Kelly JP, Leonard BE. The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression. Pharmacology, Biochemistry, and Behavior. 62: 619-23. PMID 10208367 DOI: 10.1016/S0091-3057(98)00181-6  0.316
1999 Redmond AM, Harkin A, Kelly JP, Leonard BE. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 165-70. PMID 10082243 DOI: 10.1016/S0924-977X(98)00023-6  0.34
1999 Kelly JP, Leonard BE. An investigation of the antidepressant properties of lofepramine and its desmethylated metabolites in the forced swim and olfactory bulbectomized rat models of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 101-5. PMID 10082234 DOI: 10.1016/S0924-977X(98)00010-8  0.334
1999 Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. European Journal of Pharmacology. 364: 123-32. PMID 9932714 DOI: 10.1016/S0014-2999(98)00838-3  0.603
1999 Harkin A, Naughton M, Cryan J, Kelly J, Leonard B. Differential modification of d-fenfluramine-induced serotonergic responses by acute and chronic sertraline and fluoxetine administration to rats European Neuropsychopharmacology. 9: 242. DOI: 10.1016/S0924-977X(99)80211-9  0.462
1999 Leonard BE. New developments in the pharmacological treatment of anxiety Human Psychopharmacology. 14: S52-S59. DOI: 10.1002/(SICI)1099-1077(199908)14:1+3.0.CO;2-G  0.314
1999 Connor TJ, McNamara MG, Kelly JP, Leonard BE. 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat Human Psychopharmacology. 14: 95-104. DOI: 10.1002/(SICI)1099-1077(199903)14:2<95::AID-HUP72>3.0.CO;2-7  0.547
1999 Leonard BE. Neuropharmacology of antidepressants that modify central noradrenergic and serotonergic function: A short review Human Psychopharmacology. 14: 75-81. DOI: 10.1002/(SICI)1099-1077(199903)14:2<75::AID-HUP68>3.0.CO;2-X  0.333
1999 Shen Y, Connor TJ, Kelly JP, Leonard BE. Effects of chronic dietary supplementation with ω3 and ω6 fatty acid rich oils on lipopolysaccharide-induced behavioural responses and interleukin-1β secretion in the rat Medical Science Research. 27: 291-294.  0.468
1998 Cryan JF, McGrath C, Leonard BE, Norman TR. Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? European Journal of Pharmacology. 352: 23-8. PMID 9718263 DOI: 10.1016/S0014-2999(98)00402-6  0.515
1998 Faherty CJ, Harkin AJ, Leonard BE. The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment. European Journal of Pharmacology. 346: 15-21. PMID 9617747 DOI: 10.1016/S0014-2999(98)00041-7  0.35
1998 Harkany T, O'Mahony S, Kelly JP, Soós K, Törõ I, Penke B, Luiten PG, Nyakas C, Gulya K, Leonard BE. Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behavioural Brain Research. 90: 133-45. PMID 9580273 DOI: 10.1016/S0166-4328(97)00091-0  0.524
1998 Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84: 923-33. PMID 9579794 DOI: 10.1016/S0306-4522(97)00533-2  0.555
1998 O'Mahony S, Harkany T, Rensink AA, Abrahám I, De Jong GI, Varga JL, Zarándi M, Penke B, Nyakas C, Luiten PG, Leonard BE. Beta-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockade. Brain Research Bulletin. 45: 405-11. PMID 9527015 DOI: 10.1016/S0361-9230(97)00405-X  0.518
1998 Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE. Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology. 38: 253-60. PMID 9506825 DOI: 10.1016/S0162-3109(97)00084-2  0.576
1998 Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences. 62: 583-606. PMID 9472719 DOI: 10.1016/S0024-3205(97)00990-9  0.573
1998 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacology, Biochemistry, and Behavior. 59: 171-7. PMID 9443552 DOI: 10.1016/S0091-3057(97)00316-X  0.578
1998 Kellihera P, Connor TJ, Sanchez C, Kelly JP, Leonard BE. CIRCADIAN ALTERATIONS IN THE RAT FORCED SWIM TEST Behavioural Pharmacology. 9: S49. DOI: 10.1097/00008877-199808000-00099  0.53
1998 Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of chronic antidepressant treatment on behavioural, neurochemical and endocrine changes following forced swim test exposure European Neuropsychopharmacology. 8. DOI: 10.1016/S0924-977X(98)80288-5  0.536
1998 Cryan J, Redmond A, Kelly J, Leonard B. Does the 5-HTIA agonist, flesinoxan and the serenic, eltoprazine have antidepressant properties? — An investigation in three rodent paradigms European Neuropsychopharmacology. 8: S170-S171. DOI: 10.1016/S0924-977X(98)80221-6  0.435
1997 Borsini F, Cesana R, Kelly J, Leonard BE, McNamara M, Richards J, Seiden L. BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology. 134: 378-86. PMID 9452180 DOI: 10.1007/S002130050474  0.328
1997 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacology, Biochemistry, and Behavior. 58: 961-7. PMID 9408201 DOI: 10.1016/S0091-3057(97)00028-2  0.566
1997 Caldwell MA, Reymann JM, Allain H, Leonard BE, Bentué-Ferrer D. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Research. 771: 305-18. PMID 9401751 DOI: 10.1016/S0006-8993(97)00817-2  0.304
1997 Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: an update. Pharmacology & Therapeutics. 74: 299-316. PMID 9352586 DOI: 10.1016/S0163-7258(97)00004-1  0.387
1997 O'Mahony S, Noonan D, Harkány T, De Jong GI, Nyakas C, Leonard BE. Ifenprodil attenuates the loss of parietal cortical parvalbumin immunoreactivity after focal cerebral ischemia in the mouse. Neurobiology (Budapest, Hungary). 5: 79-82. PMID 9302704  0.426
1997 Redmond AM, Kelly JP, Leonard BE. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacology, Biochemistry, and Behavior. 58: 355-9. PMID 9300592 DOI: 10.1016/S0091-3057(97)00259-1  0.377
1997 Song C, Earley B, Leonard BE. Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat. Neuropsychobiology. 35: 200-4. PMID 9246222 DOI: 10.1159/000119345  0.335
1997 Leonard BE. Noradrenaline in basic models of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 7: S11-6; discussion S7. PMID 9169306 DOI: 10.1016/S0924-977X(97)00415-X  0.368
1997 Cryan JF, Redmond AM, Kelly JP, Leonard BE. The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 7: 109-14. PMID 9169298 DOI: 10.1016/S0924-977X(96)00391-4  0.519
1997 Song C, Earley B, Leonard BE. Effect of chronic treatment with piracetam and tacrine on some changes caused by thymectomy in the rat brain. Pharmacology, Biochemistry, and Behavior. 56: 697-704. PMID 9130296 DOI: 10.1016/S0091-3057(96)00410-8  0.353
1997 Faherty CJ, Earley B, Leonard BE. Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. Journal of Psychopharmacology (Oxford, England). 11: 53-8. PMID 9097894 DOI: 10.1177/026988119701100114  0.321
1997 Leonard BE, Song C. Changes in the immune-endocrine interrelationships in anxiety and depression Stress Medicine. 13: 217-227. DOI: 10.1002/(SICI)1099-1700(199710)13:4<217::AID-SMI742>3.0.CO;2-I  0.336
1997 Redmond AM, Leonard BE. An evaluation of the role of the noradrenergic system in the neurobiology of depression: A review Human Psychopharmacology. 12: 407-430. DOI: 10.1002/(SICI)1099-1077(199709/10)12:5<407::AID-HUP918>3.0.CO;2-1  0.327
1997 Song C, Leonard BE. Changes in behavior, neurotransmitters and neutrophil function in olfactory bulbectomized rats: Effects of chronic desipramine treatment Human Psychopharmacology. 12: 99-103. DOI: 10.1002/(SICI)1099-1077(199703/04)12:2<99::AID-HUP842>3.0.CO;2-P  0.303
1997 Connor TJ, Kelly JP, Leonard BE. Effect of acute desipramine treatment on immunological parameters in the rat Medical Science Research. 25: 209-211.  0.487
1996 Kelly JP, Leonard BE. Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats. Journal of Psychopharmacology (Oxford, England). 10: 153-6. PMID 22302893 DOI: 10.1177/026988119601000211  0.305
1996 McNamara MG, Kelly JP, Leonard BE. Some behavioural and neurochemical effects of ipsapirone in two rodent models of depression. Journal of Psychopharmacology (Oxford, England). 10: 126-33. PMID 22302889 DOI: 10.1177/026988119601000207  0.361
1996 Ryan PM, Kelly JP, Chambers PL, Leonard BE. The characterization of oxotremorine-induced hypothermic response in the rat. Pharmacology & Toxicology. 79: 238-40. PMID 8936556 DOI: 10.1111/J.1600-0773.1996.Tb00266.X  0.322
1996 Song C, Earley B, Leonard BE. Behavioural and immunological effects of the antihistamine terfenadine in olfactory bulbectomized rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 157-62. PMID 8880073 DOI: 10.1016/0924-977X(95)00073-X  0.377
1996 Song C, Earley B, Leonard BE. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression. Brain, Behavior, and Immunity. 10: 1-16. PMID 8735565 DOI: 10.1006/brbi.1996.0001  0.365
1996 Leonard BE, Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacology, Biochemistry, and Behavior. 54: 299-303. PMID 8728571 DOI: 10.1016/0091-3057(95)02158-2  0.34
1996 Souza IJD, Darcy P, Kelly JP, Harkin AJ, Leonard BE. The pharmacological and toxicological effects of a single oral administration of MDMA in the rat Toxicology Letters. 88: 65. DOI: 10.1016/S0378-4274(96)80233-5  0.307
1996 Redmond AM, Kelly JP, Leonard BE. The NMDA receptor and the olfactory bulbectomised rat model of depression European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)83239-1  0.314
1996 Cryan JF, Redmond AM, Kelly JP, Leonard BE. Does the serenic eltoprazine have antidepressant potential? - An investigation in three rodent paradigms Medical Science Research. 24: 719-720.  0.356
1995 Song C, Leonard BE. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation. 2: 263-73. PMID 8739199 DOI: 10.1159/000097205  0.332
1995 Song C, Earley B, Leonard BE. Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress? Annals of the New York Academy of Sciences. 771: 55-72. PMID 8597429 DOI: 10.1111/J.1749-6632.1995.Tb44670.X  0.334
1995 McNamara MG, Kelly JP, Leonard BE. Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacology, Biochemistry, and Behavior. 52: 479-84. PMID 8545462 DOI: 10.1016/0091-3057(95)00206-C  0.352
1995 Leonard BE. Biological markers of serotonin receptors in depression and animal models of depression International Review of Psychiatry. 7: 69-83. DOI: 10.3109/09540269509022976  0.341
1995 Leonard BE. Mechanisms of Action of Antidepressants Cns Drugs. 4: 1-12. DOI: 10.2165/00023210-199500041-00003  0.339
1995 Ryan PM, Kelly JP, Leonard BE, Chambers PL. A comparison of the behavioural toxicity of antidepressants in the rat Toxicology Letters. 78: 72. DOI: 10.1016/0378-4274(95)94921-3  0.322
1995 Leonard BE. SSRI differentiation: Pharmacology and pharmacokinetics Human Psychopharmacology. 10. DOI: 10.1002/hup.470100903  0.303
1995 McNamara MG, Kelly JP, Leonard BE. The effect of acute MDMA administration on body temperature, serum corticosterone and neurotransmitter concentrations in male and female rats Human Psychopharmacology-Clinical and Experimental. 10: 373-383. DOI: 10.1002/Hup.470100503  0.307
1995 Song C, Leonard BE. The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function Human Psychopharmacology-Clinical and Experimental. 10: 7-18. DOI: 10.1002/Hup.470100103  0.377
1994 Cai Song, Leonard BE. The effects of chronic lithium chloride administration on some behavioural and immunological changes in the bilaterally olfactory bulbectomized rat. Journal of Psychopharmacology (Oxford, England). 8: 40-7. PMID 22298479 DOI: 10.1177/026988119400800107  0.331
1994 Song C, Killeen AA, Leonard BE. Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. Neuropsychobiology. 30: 24-8. PMID 7969855 DOI: 10.1159/000119131  0.351
1994 O'Connell A, Earley B, Leonard BE. Phencyclidine prevents spatial navigation and passive avoidance deficits in ibotenate lesioned rats. Neuropharmacology. 33: 1095-101. PMID 7838322 DOI: 10.1016/0028-3908(94)90148-1  0.311
1994 Kelly JP, Leonard BE. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33: 1011-6. PMID 7531300 DOI: 10.1016/0028-3908(94)90160-0  0.385
1994 Norman TR, Leonard BE. Fast-Acting Antidepressants Cns Drugs. 2: 120-131. DOI: 10.2165/00023210-199402020-00005  0.324
1994 Leonard BE. Biochemical Strategies for the Development of Antidepressants Cns Drugs. 1: 285-304. DOI: 10.2165/00023210-199401040-00006  0.316
1994 Ryan PM, Kelly JP, Leonard BE, Chambers PL. The interactions between antidepressants and oxotremorine-lnduced tremors and hypothermia in rats Toxicology Letters. 74: 71. DOI: 10.1016/0378-4274(94)90401-4  0.301
1994 Song C, Kelly JP, Leonard BE. The effect of stressful behavioural exposure on endocrine and immune parameters in the rat Stress Medicine. 10: 239-245. DOI: 10.1002/Smi.2460100406  0.319
1994 Earley B, Glennon M, Lally M, Leonard BE, Junien J. Autoradiographic distribution of cholinergic muscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine Human Psychopharmacology-Clinical and Experimental. 9: 397-407. DOI: 10.1002/Hup.470090603  0.367
1994 Song C, Leonard BE. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune functions in the olfactory bulbectomized rat Human Psychopharmacology-Clinical and Experimental. 9: 135-146. DOI: 10.1002/Hup.470090208  0.385
1993 Leonard BE. Endocoids in depression: do antidepressants alter endocoids that affect the serotonergic system? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 505-14. PMID 8395698 DOI: 10.1016/0278-5846(93)90001-9  0.317
1993 McAdams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 971-84. PMID 8278606 DOI: 10.1016/0278-5846(93)90024-M  0.303
1993 Song C, Kelly J, Leonard BE. Is the state of leucocyte adhesiveness/aggregation an immune marker of stress in the olfactory bulbectomized rat? Stress Medicine. 9: 255-258. DOI: 10.1002/Smi.2460090408  0.33
1992 Earley B, Burke M, Leonard BE. Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochemistry International. 21: 351-66. PMID 1284623 DOI: 10.1016/0197-0186(92)90186-U  0.326
1990 van Riezen H, Leonard BE. Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacology & Therapeutics. 47: 21-34. PMID 2195555 DOI: 10.1016/0163-7258(90)90043-2  0.33
1990 O'Neill B, Leonard BE. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression. Journal of Affective Disorders. 19: 265-72. PMID 2146303 DOI: 10.1016/0165-0327(90)90104-G  0.307
1990 Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL. A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+) SKF 10,047 in the trimethyltin rat model. Neuropharmacology. 29: 695-703. PMID 1980347 DOI: 10.1016/0028-3908(90)90121-7  0.342
1990 Butler J, Leonard BE. Comparison of mianserin and dothiepin treatment on the serotonergic system in depressed patients Human Psychopharmacology-Clinical and Experimental. 5: 369-372. DOI: 10.1002/Hup.470050410  0.305
1989 Earley B, Burke M, Leonard BE. Effects of captopril on locomotor activity, passive avoidance behaviour and spatial memory tasks in the trimethyltin-treated rat. Neuropsychobiology. 22: 49-56. PMID 2700775 DOI: 10.1159/000118591  0.3
1988 O'Connor WT, Leonard BE. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 41-51. PMID 3363165 DOI: 10.1016/0278-5846(88)90060-7  0.361
1987 Leonard BE, O'Connor WT. The effect of chronically administered mianserin, 8-hydroxymianserin and desmethylmianserin on the 'open field' behaviour and brain noradrenaline metabolism in the olfactory bulbectomized rat. Neuropsychobiology. 18: 118-21. PMID 3453427 DOI: 10.1159/000118404  0.304
1986 Menez JF, Leonard BE. The effect of a putative antidepressant, an O2-substituted derivative of barbitone on apomorphine induced hypomotility. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 703-8. PMID 3809521 DOI: 10.1016/0278-5846(86)90054-0  0.321
1986 Healy D, O'Halloran A, Carney PA, Leonard BE. Variations in platelet 5-hydroxytryptamine in control and depressed populations. Journal of Psychiatric Research. 20: 345-53. PMID 3806429 DOI: 10.1016/0022-3956(86)90037-3  0.314
1986 O'Connor WT, Leonard BE. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus. Neuropharmacology. 25: 267-70. PMID 3703175 DOI: 10.1016/0028-3908(86)90250-9  0.335
1986 Healy D, O'Halloran A, Leonard BE. Increases in platelet 5HT uptake rates following treatment with "uptake inhibiting" drugs. International Clinical Psychopharmacology. 1: 332-9. PMID 3559157 DOI: 10.1097/00004850-198610000-00008  0.303
1986 Healy D, O'Halloran A, Carney PA, Leonard BE. Platelet 5-HT uptake in delusional and nondelusional depressions. Journal of Affective Disorders. 10: 233-9. PMID 2943778 DOI: 10.1016/0165-0327(86)90010-8  0.313
1986 Leonard BE. Neurotransmitter receptors, endocrine responses and the biological substrates of depression: A review Human Psychopharmacology-Clinical and Experimental. 1: 3-21. DOI: 10.1002/Hup.470010103  0.341
1985 Foster-Smith K, Leonard BE. Acute and chronic effects of dextropropoxyphene on behaviour and central inhibitory neurotransmission in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 361-7. PMID 2999872 DOI: 10.1016/0278-5846(85)90188-5  0.304
1985 Healy D, Carney PA, O'Halloran A, Leonard BE. Peripheral adrenoceptors and serotonin receptors in depression. Changes associated with response to treatment with trazodone or amitriptyline. Journal of Affective Disorders. 9: 285-96. PMID 2934461 DOI: 10.1016/0165-0327(85)90059-X  0.328
1985 O'Connor WT, Earley B, Leonard BE. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression. British Journal of Clinical Pharmacology. 19: 49S-56S. PMID 2859878 DOI: 10.1111/J.1365-2125.1985.Tb02742.X  0.336
1985 Górka Z, Earley B, Leonard BE. Effect of bilateral olfactory bulbectomy in the rat, alone or in combination with antidepressants, on the learned immobility model of depression. Neuropsychobiology. 13: 26-30. PMID 2412181 DOI: 10.1159/000118158  0.358
1985 Leonard BE. New antidepressants and the biology of depression Stress Medicine. 1: 9-16. DOI: 10.1002/Smi.2460010104  0.347
1984 Healy D, Carney PA, Leonard BE. Biochemical correlates of antidepressant response. Results of a trazodone versus amitriptyline trial. Psychopathology. 17: 82-7. PMID 6326178 DOI: 10.1159/000284096  0.335
1984 Jancsàr SM, Leonard BE. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8: 263-9. PMID 6204359 DOI: 10.1016/0278-5846(84)90163-5  0.31
1984 Leonard BE. Pharmacology of new antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8: 97-108. PMID 6145191 DOI: 10.1016/0278-5846(84)90140-4  0.36
1984 Jancsár SM, Leonard BE. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat. Neuropharmacology. 23: 1065-70. PMID 6083502 DOI: 10.1016/0028-3908(84)90130-8  0.329
1983 Jancsár SM, Leonard BE. Behavioural and neurochemical interactions between chronic reserpine and chronic antidepressants. A possible model for the detection of atypical antidepressants. Biochemical Pharmacology. 32: 1569-71. PMID 6134530 DOI: 10.1016/0006-2952(83)90329-5  0.336
1982 Leonard BE. Current status of the biogenic amine theory of depression. Neurochemistry International. 4: 339-50. PMID 20487885 DOI: 10.1016/0197-0186(82)90074-2  0.308
1982 Healy D, Carney PA, Leonard BE. Monoamine-related markers of depression: changes following treatment. Journal of Psychiatric Research. 17: 251-60. PMID 6821276 DOI: 10.1016/0022-3956(82)90003-6  0.324
1980 Kenny M, Lynch M, Leonard BE. Induction of two distinct behavioural responses by chronic treatment with ampomorphine. Journal of Neuroscience Research. 5: 35-42. PMID 7189789 DOI: 10.1002/jnr.490050106  0.342
1980 Kenny M, Leonard BE. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs. Journal of Neuroscience Research. 5: 291-8. PMID 6107385 DOI: 10.1002/jnr.490050405  0.328
1980 Kenny M, Leonard BE. The effects of strain differences and emotional status of rats on the behavioural and neurochemical effects of chronic treatment with apomorphine. Progress in Neuro-Psychopharmacology. 4: 161-70. PMID 6105688 DOI: 10.1016/0364-7722(80)90033-8  0.327
1979 Fludder JM, Leonard BE. The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrealine in the rat brain in vivo. Biochemical Pharmacology. 28: 2333-6. PMID 497015 DOI: 10.1016/0006-2952(79)90696-8  0.303
1979 Fludder JM, Leonard BE. Chronic effects of mianserin on noradrenaline metabolism in the rat brain: evidence for a pre-synaptic alpha-adrenolytic action in vivo. Psychopharmacology. 64: 329-32. PMID 41280 DOI: 10.1007/Bf00427519  0.322
1978 Lynch MA, Kenny M, Leonard BE. Effect of D-amphetamine on the behaviour of rats in the open field apparatus: interaction with four neuroleptics and changes in biogenic amine metabolsm in discrete brain regions. Irish Journal of Medical Science. 147: 337-50. PMID 711421 DOI: 10.1007/Bf02939429  0.317
1978 Lynch MA, Leonard BE. Changes in brain gamma-aminobutyric acid concentrations following acute and chronic amphetamine administration and during post amphetamine depression. Biochemical Pharmacology. 27: 1853-5. PMID 568471 DOI: 10.1016/0006-2952(78)90032-1  0.304
1978 Ramaekers F, Rigter H, Leonard BE. Parallel changes in behaviour and hippocampal monoamine metabolism in rats after administration of ACTH-analogues. Pharmacology, Biochemistry, and Behavior. 8: 547-51. PMID 209481 DOI: 10.1016/0091-3057(78)90386-6  0.327
1978 McNulty J, O'Donovan DJ, Leonard BE. The acute and chronic effects of D-amphetamine, chlorpromazine, amitriptyline and lithium chloride on adenosine 5-triphosphatases in different regions of the rat brain. Biochemical Pharmacology. 27: 1049-53. PMID 148891 DOI: 10.1016/0006-2952(78)90157-0  0.304
1978 McNulty J, Leonard BE. The acute effects of amphetamine, chlorpromazine, amitriptyline and lithium on adenosine 5-triphosphatase activity in the cortex of the rat brain. Biochemical Pharmacology. 27: 132-3. PMID 145866 DOI: 10.1016/0006-2952(78)90273-3  0.302
1977 Lynch M, Kenny M, Leonard BE. The effect of chronic administration of d‐amphetamine on regional changes in catecholamines in the rat brain Journal of Neuroscience Research. 3: 295-300. PMID 615278 DOI: 10.1002/Jnr.490030408  0.327
1972 Tonge SR, Leonard BE. Partial antagonism of the behavioural and neurochemical effects of phencyclidine by drugs affecting monoamine metabolism Psychopharmacologia. 24: 516-520. PMID 5034506 DOI: 10.1007/BF00423442  0.326
1972 Tonge SR, Leonard BE. Interaction of phencyclidine with drugs affecting noradrenaline metabolism in the rat brain Psychopharmacology. 23: 86-90. PMID 5018980 DOI: 10.1007/Bf00414416  0.307
Low-probability matches (unlikely to be authored by this person)
1993 Leonard BE. 5HT receptor subtypes in anxiety disorders and depression European Neuropsychopharmacology. 3: 305-306. DOI: 10.1016/0924-977X(93)90087-3  0.299
1995 Kelly JP, O'Halloran A, Leonard BE. P-11-27 Time and dose dependent behavioural and physiological effects of repeated administration of (+)-amphetamine to rats European Neuropsychopharmacology. 5: 413. DOI: 10.1016/0924-977X(95)90779-D  0.298
1996 Caldwell MA, Reymann JM, Bentue-Ferrer D, Allain H, Leonard BE. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat. Neuropsychobiology. 34: 117-24. PMID 8916068 DOI: 10.1159/000119302  0.298
2000 Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, Leonard BE, Gandon J, de Certaines JD. An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Research. 879: 193-9. PMID 11011022 DOI: 10.1016/S0006-8993(00)02619-6  0.298
1978 Fludder JM, Leonard BE. The action of the antidepressant drug mianserin on pre-synaptic alpha-adrenergic receptors in the rat brain in vivo. Neuropharmacology. 17: 1058-60. PMID 218134 DOI: 10.1016/0028-3908(78)90036-9  0.297
1979 Earley CJ, Leonard BE. The effects of castration and hormone replacement on runway behaviour and GABA concentrations in the septum. Irish Journal of Medical Science. 148: 227-231. PMID 27517425 DOI: 10.1007/Bf02938087  0.297
1995 Leonard BE, Faherty C, Earley B. P-2-22 Motor effects of some selective serotonin reuptake inhibitors following direct injection into the red nucleus of the rat: Evidence for involvement of sigma receptors European Neuropsychopharmacology. 5: 281-282. DOI: 10.1016/0924-977X(95)90387-S  0.297
2002 Leonard BE. Presidential Address - Thursday 12 September 2002: STRESS, DEPRESSION AND THE IMMUNE SYSTEM. Stress (Amsterdam, Netherlands). 5: 2. PMID 29480056 DOI: 10.1080/10253890.2002.11978455  0.297
1995 Earley B, Glennon M, Leonard BE, Junien JL. Effects of JO 1784, a selective sigma ligand, on the autoradiographic localization of M1 and M2 muscarinic receptor subtypes in trimethyltin treated rats. Neurochemistry International. 26: 559-70. PMID 7670359 DOI: 10.1016/0197-0186(95)00004-R  0.297
1991 Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Research. 546: 282-6. PMID 1676927 DOI: 10.1016/0006-8993(91)91492-J  0.297
2000 Naughton M, Mulrooney JB, Leonard BE. A review of the role of serotonin receptors in psychiatric disorders. Human Psychopharmacology. 15: 397-415. PMID 12404302 DOI: 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L  0.297
2004 Song C, Leonard BE, Horrobin DF. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress (Amsterdam, Netherlands). 7: 43-54. PMID 15204032 DOI: 10.1080/10253890410001667188  0.296
1990 Leonard BE. Stress and the immune system: Immunological aspects of depressive illness International Review of Psychiatry. 2: 321-330. DOI: 10.3109/09540269009026603  0.296
2000 Leonard BE. Stress, depression and the immune system Stress Medicine. 16: 133-137. DOI: 10.1002/(SICI)1099-1700(200004)16:3<133::AID-SMI876>3.0.CO;2-9  0.295
2009 Leonard BE, Myint AM. Immune dysfunction, depression and neurodegeneration. Acta Neuropsychiatrica. 21: 45-6. PMID 25384869 DOI: 10.1017/S0924270800032713  0.295
1989 Earley B, Biegon A, Leonard BE. Quantitative autoradiographic analysis of muscarinic receptors and quantitative histochemistry of acetylcholinesterase in the rat brain after trimethyltin intoxication. Neurochemistry International. 15: 475-83. PMID 20504522 DOI: 10.1016/0197-0186(89)90166-6  0.294
1994 O'Connell A, Earley B, Leonard BE. The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat. Neurochemistry International. 25: 555-66. PMID 7894332 DOI: 10.1016/0197-0186(94)90154-6  0.294
1996 O'Connell AW, Earley B, Leonard BE. The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat. Pharmacology & Toxicology. 78: 296-302. PMID 8737963 DOI: 10.1111/J.1600-0773.1996.Tb01378.X  0.294
1987 Healy D, Leonard BE. Monoamine transport in depression: kinetics and dynamics. Journal of Affective Disorders. 12: 91-103. PMID 3036923 DOI: 10.1016/0165-0327(87)90001-2  0.293
2000 Harkin A, Kelly JP, Frawley J, O'Donnell JM, Leonard BE. Test conditions influence the response to a drug challenge in rodents. Pharmacology, Biochemistry, and Behavior. 65: 389-98. PMID 10683478 DOI: 10.1016/S0091-3057(99)00210-5  0.293
1997 De Souza I, Kelly JP, Harkin AJ, Leonard BE. An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxymethamphetamine (MDMA) in the rat. Pharmacology & Toxicology. 80: 207-10. PMID 9181598 DOI: 10.1111/J.1600-0773.1997.Tb01961.X  0.293
1978 Earley CJ, Leonard BE. Behavioural studies on the effects of d-amphetamine and estradiol benzoate alone and in combination. Psychopharmacology. 56: 179-83. PMID 417368 DOI: 10.1007/Bf00431846  0.293
1998 Kelly JP, Leonard BE. Models and responses in depression and aggression. Biochemical Society Transactions. 26: 61-5. PMID 10909758 DOI: 10.1042/Bst0260061  0.292
2005 Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders. 88: 167-73. PMID 16126278 DOI: 10.1016/j.jad.2005.07.008  0.291
2008 Van den Hove DL, Blanco CE, Scheepens A, Desbonnet L, Myint AM, Leonard BE, Prickaerts J, Steinbusch HW. Prenatal maternal paroxetine treatment and neonatal mortality in the rat: a preliminary study. Neonatology. 93: 52-5. PMID 17652957 DOI: 10.1159/000106433  0.29
1999 Leonard BE. Therapeutic applications of benzodiazepine receptor ligands in anxiety Human Psychopharmacology. 14: 125-135. DOI: 10.1002/(SICI)1099-1077(199903)14:2<125::AID-HUP79>3.0.CO;2-X  0.289
1995 O'Neill M, Caldwell M, Earley B, Canney M, O'Halloran A, Kelly J, Leonard BE, Junien JL. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. European Journal of Pharmacology. 283: 217-25. PMID 7498313 DOI: 10.1016/0014-2999(95)00356-P  0.289
2001 Leonard BE. An introduction to enantiomers in psychopharmacology. Human Psychopharmacology. 16: S79-S84. PMID 12404712 DOI: 10.1002/hup.335  0.289
1984 Carney PA, Healy D, Leonard BE. A double-blind study to compare trazodone with amitriptyline in depressed patients. Psychopathology. 17: 37-8. PMID 6371877 DOI: 10.1159/000284091  0.288
2003 Song C, Li X, Leonard BE, Horrobin DF. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. Journal of Lipid Research. 44: 1984-91. PMID 12837849 DOI: 10.1194/jlr.M300217-JLR200  0.288
1979 Earley CJ, Leonard BE. Effects of prior exposure on conditioned taste aversion in the rat: androgen- and estrogen-dependent events. Journal of Comparative and Physiological Psychology. 93: 793-805. PMID 512099 DOI: 10.1037/H0077620  0.288
1999 Darcy P, Dredge K, Kellehir P, Kelly JP, Leonard BE, Chambers PL. Acute toxicity profile of maprotiline in the rat. Pharmacology & Toxicology. 85: 276-81. PMID 10628903 DOI: 10.1111/J.1600-0773.1999.Tb02022.X  0.285
1987 Leonard BE. Depression: A psychobiological Synthesis. Willner, P. (ed.) John Wiley & Sons, 1985. Price £57.60. ISBN 0 471 80671 4. Human Psychopharmacology-Clinical and Experimental. 2: 248-249. DOI: 10.1002/Hup.470020410  0.285
1971 Tonge SR, Leonard BE. Variation in hydroxytryptamine metabolism in the rat: effects on the neurochemical response to phencyclidine. Journal of Pharmacy and Pharmacology. 23: 711-712. PMID 4398254 DOI: 10.1111/J.2042-7158.1971.Tb08752.X  0.285
1994 Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. Journal of Affective Disorders. 30: 283-8. PMID 7516941 DOI: 10.1016/0165-0327(94)90135-X  0.284
2007 Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: S1-207. PMID 18096106 DOI: 10.1017/S1461145707008255  0.284
1988 Leonard BE. Stress, the immune system and psychiatric illness Stress Medicine. 4: 207-213. DOI: 10.1002/Smi.2460040405  0.283
1991 Duffy O, Menez JF, Floch HH, Leonard BE. Changes in whole brain membranes of rats following pre- and post-natal exposure to ethanol. Alcohol and Alcoholism (Oxford, Oxfordshire). 26: 605-13. PMID 1804140 DOI: 10.1093/Oxfordjournals.Alcalc.A045164  0.283
1979 Earley CJ, Leonard BE. Consequences of reward and nonreward conditions: runway behavior, neurotransmitters and physiological indicators of stress. Pharmacology, Biochemistry, and Behavior. 11: 215-9. PMID 41263 DOI: 10.1016/0091-3057(79)90016-9  0.283
1992 McAdams C, Colohan FJ, Brophy J, Leonard BE. Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biological Psychiatry. 32: 296-8. PMID 1420645 DOI: 10.1016/0006-3223(92)90112-D  0.282
1998 Song C, Leonard BE. Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. European Journal of Pharmacology. 345: 79-87. PMID 9593598 DOI: 10.1016/S0014-2999(97)01592-6  0.282
2011 Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 659-63. PMID 21376099 DOI: 10.1016/J.Pnpbp.2011.02.019  0.282
1998 Healy DG, Kelly JP, Leonard BE. Corticosterone influences the NMDA receptor antagonist MK-801 induced hyperactivity in the rat. Biochemical Society Transactions. 26: S23. PMID 10909781 DOI: 10.1042/Bst026S023  0.282
1974 Leonard BE, Neuhoff V, Tonge S. The Effect of the Chronic Administration of D-Amphetamine upon Circadian Changes in Amino Acids in the Pineal and Pituitary Glands of the Rat Zeitschrift FüR Naturforschung C. 29: 767-772. PMID 4281206 DOI: 10.1515/Znc-1974-11-1220  0.282
2004 Leonard BE. Pharmacotherapy of Depression. Edited by D. A. Ciraulo and R. I. Shader. Humana: Humana Press, New Jersey, USA. 2004. ISBN 1588291391. Price: £97.50 Human Psychopharmacology-Clinical and Experimental. 19: 588-588. DOI: 10.1002/Hup.629  0.282
1998 Harkin AJ, Kelly JP, Nsimba SE, Leonard BE. Lessons From An Apomorphine Challenge Test In Rats Behavioural Pharmacology. 9. DOI: 10.1097/00008877-199808000-00082  0.282
1989 Manning-Sayi J, Leonard BE. Studies on the nöotropic potential of some angiotensin converting enzyme inhibitors in the mouse. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 953-62. PMID 2682788 DOI: 10.1016/0278-5846(89)90046-8  0.282
2007 Leonard BE. Depression and physical illness. Edited by Andrew Steptoe. Cambridge University Press (2007) ISBN‐13978‐0‐521‐60360‐7 pp. 421 Human Psychopharmacology-Clinical and Experimental. 22: 253-254. DOI: 10.1002/Hup.822  0.281
1998 Dredge K, Kelly JP, Leonard BE. A comparison of the effect of a single dose of imipramine (IMI) and dexamethasone (DEX) on some immunotoxicological parameters in rats Toxicology Letters. 95: 177. DOI: 10.1016/S0378-4274(98)80707-8  0.28
1975 Leonard BE, Neuhoff V, Tonge SR. The effect of the chronic administration of D‐amphetamine upon circadian changes in amino acids in the pineal and pituitary glands of the rat Journal of Neuroscience Research. 1: 83-92. PMID 1223321 DOI: 10.1002/Jnr.490010108  0.28
1995 Maginn M, Caldwell M, Kelly JP, Leonard BE. The effect of 2-amino-3-phosphonopropionic acid (AP-3) in the gerbil model of cerebral ischaemia. European Journal of Pharmacology. 282: 259-62. PMID 7498286 DOI: 10.1016/0014-2999(95)00400-F  0.278
1997 Maginn M, Kelly JP, Leonard BE. Protective effects of vanoxeamine (GBR 12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia. Pharmacology, Biochemistry, and Behavior. 56: 727-35. PMID 9130300 DOI: 10.1016/S0091-3057(96)00409-1  0.278
1990 Corbett R, Menez JF, Leonard BE. The effect of chronic alcohol administration on platelet [(3)H]5-hydroxytryptamine uptake and membrane lipid composition. Neurochemistry International. 16: 95-8. PMID 20504545 DOI: 10.1016/0197-0186(90)90128-G  0.277
1994 O'Connell A, Earley B, Leonard BE. Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochemistry International. 25: 243-52. PMID 7833792 DOI: 10.1016/0197-0186(94)90068-X  0.277
1978 Earley CJ, Leonard BE. Androgenic involvement in conditioned taste aversion. Hormones and Behavior. 11: 1-11. PMID 748139 DOI: 10.1016/0018-506X(78)90053-3  0.275
1996 Leonard BE, Faherty C. SSRIs and movement disorders: Is serotonin the culprit? Human Psychopharmacology. 11: S75-S82. DOI: 10.1002/(SICI)1099-1077(199606)11:2+3.0.CO;2-B  0.275
1992 Butler J, O'Halloran A, Leonard BE. The Galway Study of Panic Disorder. II: Changes in some peripheral markers of noradrenergic and serotonergic function in DSM III-R panic disorder. Journal of Affective Disorders. 26: 89-99. PMID 1447432 DOI: 10.1016/0165-0327(92)90039-9  0.274
2006 Leonard BE. Book reviewStress, the Brain and Depression, H.M. van Praag, E.R. de Kloet, J. van Os, Cambridge University Press (2004), (reprinted 2005), ISBN 0-521-62147 X Journal of Chemical Neuroanatomy. 32. DOI: 10.1016/J.Jchemneu.2006.03.001  0.272
2008 Grunze H, Baghai TC, Barrett B, Goodwin G, Markowitz JC, Knapp M, Leonard BE, Sartorius N. Antidepressant medications and other treatments of depressive disorders: A CINP Task Force report - A reply to Ban International Journal of Neuropsychopharmacology. 11: 587-589. DOI: 10.1017/S146114570800881X  0.271
2003 Song C, Phillips AG, Leonard B. Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. The European Journal of Neuroscience. 18: 1739-43. PMID 14622208 DOI: 10.1046/j.1460-9568.2003.02886.x  0.271
1995 Nugent DF, Dinan TG, Leonard BE. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. Journal of Affective Disorders. 33: 227-31. PMID 7790676 DOI: 10.1016/0165-0327(94)00093-O  0.27
2004 Song C, Phillips AG, Leonard BE, Horrobin DF. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Molecular Psychiatry. 9: 630-8. PMID 14699427 DOI: 10.1038/sj.mp.4001462  0.269
1988 Leonard BE. Biochemical aspects of therapy-resistant depression. The British Journal of Psychiatry : the Journal of Mental Science. 152: 453-9. PMID 3048524 DOI: 10.1192/Bjp.152.4.453  0.269
2005 Abi-Dargham A, Allgulander C, Gureje O, Jenkins R, Kalaria RN, Leonard B, Njenga F, Pinder RM, Siever LJ, Svensson T, Robbins TW, Horn G, Gustafsson J, Barnes C, Connor JRC, et al. CINP 2005 Regional Meeting, 20-22 April 2005 South African Journal of Psychiatry. 11: 10. DOI: 10.4102/sajpsychiatry.v11i1.92  0.269
1996 O'Neill M, Canney M, Earley B, Junien JL, Leonard BE. The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochemistry International. 28: 193-207. PMID 8719709 DOI: 10.1016/0197-0186(95)00065-8  0.269
1992 Duffy O, Ménez JF, Leonard BE. Effects of an oil enriched in gamma linolenic acid on locomotor activity and behaviour in the Morris Maze, following in utero ethanol exposure in rats. Drug and Alcohol Dependence. 30: 65-70. PMID 1317288 DOI: 10.1016/0376-8716(92)90037-D  0.268
1985 Keane B, Leonard BE. The effect of ethanol administration on the activities of synaptosomal Ca2+-ATPases in rat brain Biochemical Society Transactions. 13: 969-970. DOI: 10.1042/Bst0130969  0.268
2011 Debnath M, Doyle KM, Langan C, McDonald C, Leonard B, Cannon DM. Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders Translational Neuroscience. 2: 121-137. DOI: 10.2478/s13380-011-0019-0  0.268
1989 Leonard BE. New concepts in depression Eds. M. BRILEY G. FILLON. Pierre Fabre Monograph Series Vol. 2, 1988. Pub. Macmillan Press Ltd., Basingstoke, U.K. ISBN 0-33-44133-8 Human Psychopharmacology-Clinical and Experimental. 4: 154-155. DOI: 10.1002/Hup.470040216  0.267
1993 Kelly JP, Norman TR, Leonard BE. Behavioural responses to olfactory bulbectomy in rats maintained in reversed cycle lighting European Neuropsychopharmacology. 3: 363. DOI: 10.1016/0924-977X(93)90149-G  0.266
2010 Cryan JF, Leonard BE. Modern Trends in Pharmacopsychiatry: Preface Modern Trends in Pharmacopsychiatry. 27: VII-VIII. DOI: 10.1159/000320280  0.266
1994 Nugent DF, Dinan TG, Leonard BE. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. Journal of Affective Disorders. 31: 61-6. PMID 8046161 DOI: 10.1016/0165-0327(94)90127-9  0.266
2020 de Abreu MS, Giacomini ACVV, Genario R, Rech N, Carboni J, Lakstygal AM, Amstislavskaya TG, Demin KA, Leonard BE, Vlok M, Harvey BH, Piato A, Barcellos LJG, Kalueff AV. Non-pharmacological and pharmacological approaches for psychiatric disorders: Re-appraisal and insights from zebrafish models. Pharmacology, Biochemistry, and Behavior. 172928. PMID 32289330 DOI: 10.1016/j.pbb.2020.172928  0.266
1998 Leonard BE. Advances in the drug treatment of Alzheimer's disease Human Psychopharmacology. 13: 83-90. DOI: 10.1002/(SICI)1099-1077(199803)13:2<83::AID-HUP956>3.0.CO;2-F  0.266
1986 Corbett R, Ménez JF, Leonard BE, Floch HH. Changes in neutral lipids in brain synaptosomes of rats after chronic administration of ethanol. Neuroscience Letters. 69: 198-202. PMID 3763047 DOI: 10.1016/0304-3940(86)90603-8  0.265
2012 Leonard BE, Schwarz M, Myint AM. The metabolic syndrome in schizophrenia: is inflammation a contributing cause? Journal of Psychopharmacology (Oxford, England). 26: 33-41. PMID 22472311 DOI: 10.1177/0269881111431622  0.265
1980 Morinan A, Leonard BE. Some anatomical and physiological correlates of social isolation in the young rat. Physiology & Behavior. 24: 637-40. PMID 7375588 DOI: 10.1016/0031-9384(80)90265-6  0.264
1974 Leonard BE, Neuhoff V, Tonge SR. Microanalysis of amino acids in small regions of the rat brain using dansyl chloride. Zeitschrift FüR Naturforschung C. 29: 184-186. DOI: 10.1515/Znc-1974-3-418  0.264
2009 Desbonnet L, Hove DLAvd, Myint AM, Leonard BE, Steinbusch HWM. P.1.08 Differential immune response to maternal separation stress in male and female prenatally-stressed juvenile rats European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70011-2  0.264
1983 Keane B, Leonard BE. Changes in "open field" behaviour and in some membrane-bound enzymes following the chronic administration of ethanol to the rat. Neuropharmacology. 22: 555-7. PMID 6134253 DOI: 10.1016/0028-3908(83)90179-X  0.263
1995 Redrobe JP, Kelly JP, Leonard BE, Chambers PL. The developmental effect of prenatal dietary essential fatty acid deficiency in rats Toxicology Letters. 78: 69. DOI: 10.1016/0378-4274(95)94905-V  0.261
1987 Leonard BE. A comparison of the pharmacological properties of the novel tricyclic antidepressant lofepramine with its major metabolite, desipramine: a review. International Clinical Psychopharmacology. 2: 281-97. PMID 2891742  0.26
2007 Myint AM, Kim YK, Verkerk R, Park SH, Scharpé S, Steinbusch HW, Leonard BE. Tryptophan breakdown pathway in bipolar mania. Journal of Affective Disorders. 102: 65-72. PMID 17270276 DOI: 10.1016/j.jad.2006.12.008  0.259
1995 Caldwell M, O'Neill M, Earley B, Kelly JP, Leonard BE. NG-nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia. European Journal of Pharmacology. 285: 203-6. PMID 8566140 DOI: 10.1016/0014-2999(95)00502-C  0.259
1997 Mannion L, Nugent D, Leonard B. Platelet studies in panic disorder: A review Irish Journal of Psychological Medicine. 14: 139-143. DOI: 10.1017/S0790966700003372  0.259
1990 Leonard BE. Changes in biogenic amine neurotransmitters in panic disorder Stress Medicine. 6: 267-274. DOI: 10.1002/Smi.2460060404  0.259
2011 Myint AM, Schwarz MJ, Verkerk R, Mueller HH, Zach J, Scharpé S, Steinbusch HW, Leonard BE, Kim YK. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Brain, Behavior, and Immunity. 25: 1576-81. PMID 21620952 DOI: 10.1016/j.bbi.2011.05.005  0.258
1992 Duffy O, Ménez JF, Leonard BE. Attenuation of the effects of chronic ethanol administration in the brain lipid content of the developing rat by an oil enriched in gamma linolenic acid. Drug and Alcohol Dependence. 31: 85-9. PMID 1330473 DOI: 10.1016/0376-8716(92)90012-2  0.257
1992 Corbett R, Berthou F, Leonard BE, Jean-François M. Rapid Communication: The Effects Of Chronic Administration Of Ethanol On Synaptosomal Fatty Acid Composition: Modulation By Oil Enriched With Gamma-Linolenic Acid Alcohol and Alcoholism. 27: 11-14. DOI: 10.1093/Oxfordjournals.Alcalc.A045186  0.257
1989 Keane B, Leonard BE. Rodent models of alcoholism: a review. Alcohol and Alcoholism (Oxford, Oxfordshire). 24: 299-309. PMID 2675861 DOI: 10.1093/Oxfordjournals.Alcalc.A044916  0.257
1988 Leonard BE. Pharmacological effects of serotonin reuptake inhibitors. The Journal of Clinical Psychiatry. 49: 12-7. PMID 3045106  0.257
1996 Redrobe PJ, Darcy P, Kelly JP, Horrobin D, Chambers PL, Leonard BE. The effect of a high-sucrose diet on toxicological parameters in the lactating rat Toxicology Letters. 88: 64-65. DOI: 10.1016/S0378-4274(96)80232-3  0.256
1994 Meagher J, Leonard BE. Increased 5HT‐induced platelet aggregation in mania: Lack of change following neuroleptic medication Human Psychopharmacology-Clinical and Experimental. 9: 337-342. DOI: 10.1002/Hup.470090503  0.256
2001 Leonard BE. Pocket handbook of psychiatric drug treatment. Edited by Sadock and Sadock. Lippincott, Williams and Wilkins, 2000. Pages: 330 + xxi. ISBN: 0-7817-2531-3. Price: $42.95. Human Psychopharmacology-Clinical and Experimental. 16: 429-430. DOI: 10.1002/Hup.295  0.256
2009 Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Neuropsychobiology. 59: 123-9. PMID 19390223 DOI: 10.1159/000213565  0.256
2012 Taylor M, Waight A, Leonard B. Advances in the understanding and challenges facing the management of first-episode schizophrenia Journal of Psychopharmacology. 26: 3-5. PMID 22572071 DOI: 10.1177/0269881111405364  0.255
1993 Leonard BE. Commentary on the mode of action of benzodiazepines. Journal of Psychiatric Research. 27: 193-207. PMID 7908333 DOI: 10.1016/0022-3956(93)90028-Z  0.255
1980 Leonard BE. Pharmacological properties of some "second generation" antidepressant drugs. Neuropharmacology. 19: 1175-83. PMID 6449676 DOI: 10.1016/0028-3908(80)90198-7  0.253
2002 Darcy P, Kelly JP, Leonard BE, Henry JA. The effect of lofepramine and other related agents on the motility of Tetrahymena pyriformis. Toxicology Letters. 128: 207-14. PMID 11869831 DOI: 10.1016/S0378-4274(01)00542-2  0.252
2017 Tang SW, Tang W, Leonard BE. Herbal Medicine for Psychiatric Disorders: Psychopharmacology and Neuroscience-based Nomenclature. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-48. PMID 28649903 DOI: 10.1080/15622975.2017.1346279  0.25
1994 Redrobe JP, Kelly JP, Chambers PL, Horrobin D, Leonard BE. The toxicological consequences of short-term dietary essential fatty acid deficiency in rats Toxicology Letters. 74: 68. DOI: 10.1016/0378-4274(94)90394-8  0.249
1994 Caldwell M, O'Neill M, Earley B, Leonard B. NG-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil European Journal of Pharmacology. 260: 191-200. PMID 7527344 DOI: 10.1016/0014-2999(94)90337-9  0.248
1979 Egan J, Earley CJ, Leonard BE. The effect of amitriptyline and mianserine (Org. GB94) on food motivated behaviour of rats trained in a runway: possible correlation with biogenic amine concentration in the limbic system. Psychopharmacology. 61: 143-7. PMID 108731 DOI: 10.1007/Bf00426728  0.248
2004 Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ, Akiskal H, Allain H, Ayuso-Gutiérrez J, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois M, Burrows G, ... ... Leonard B, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment World Journal of Biological Psychiatry. 5: 120-135. PMID 15346536 DOI: 10.1080/15622970410029924  0.248
2002 Leonard BE. Neurotransmitters, drugs and brain function. Edited by R. A. Webster. John Wiley and Sons, Ltd.: Chichester, 2001. ISBN: 0-471-97819-1. Price £100.00 Human Psychopharmacology-Clinical and Experimental. 17: 165-166. DOI: 10.1002/Hup.381  0.248
1993 Montgomery S, Leonard B. Differential response of new and old antidepressants. Journal of Psychopharmacology. 7: 99-100. PMID 22290379 DOI: 10.1177/026988119300700117  0.248
1990 Corbett R, Meagher JBA, Leonard BE. The effect of acute alcohol intoxication on psychometric testing and 5-HT-induced platelet aggregation in normal subjects; modulatory role of evening primrose oil Human Psychopharmacology-Clinical and Experimental. 5: 245-248. DOI: 10.1002/Hup.470050310  0.248
2003 Shu SY, Bao XM, Wu YM, Wang J, Leonard B. Hippocampal long-term potentiation attenuated by lesions in the marginal division of neostriatum Neurochemical Research. 28: 743-747. PMID 12716025 DOI: 10.1023/A:1022865801813  0.248
1994 Sweeney CPM, Redrobe JR, Kelly JR, Horrobin D, Leonard BE. Examination of the effect of route of administration and dose on the diabetogenic effects of streptozotocin Toxicology Letters. 74: 51. DOI: 10.1016/0378-4274(94)90347-6  0.247
1996 Leonard B. L-2 Comparison of the clinical and pharmacological efficacy of the presently available drugs for mood disorders European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)83812-0  0.246
1971 Tonge SR, Leonard BE. Hallucinogens and non-hallucinogens: a comparison of the effects on 5-hydroxytryptamine and noradrenaline. Life Sciences. 10: 161-168. PMID 5575788 DOI: 10.1016/0024-3205(71)90089-0  0.246
2002 Schüppel K, Brauer K, Härtig W, Grosche J, Earley B, Leonard BE, Brückner G. Perineuronal nets of extracellular matrix around hippocampal interneurons resist destruction by activated microglia in trimethyltin-treated rats. Brain Research. 958: 448-53. PMID 12470883 DOI: 10.1016/S0006-8993(02)03569-2  0.246
1992 Moran PM, LeMaître MH, Philouze V, Reymann JM, Allain H, Leonard BE. Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat. Brain Research. 595: 327-33. PMID 1281740 DOI: 10.1016/0006-8993(92)91067-O  0.245
1996 Harkin A, Kelly J, Leonard B. 5-HT uptake inhibitors attenuate the neurochemical effects of 3,4 methylenedioxymethamphetamine European Neuropsychopharmacology. 6: 45-46. DOI: 10.1016/0924-977X(96)87510-9  0.245
1991 Corbett R, Ménez JF, Floch HH, Leonard BE. The effects of chronic ethanol administration on rat liver and erythrocyte lipid composition: modulatory role of 'evening primrose oil'. Alcohol and Alcoholism (Oxford, Oxfordshire). 26: 459-64. PMID 1760057 DOI: 10.1093/Oxfordjournals.Alcalc.A045139  0.245
1996 Earley B, Canney M, Clune B, Caldwell M, Leonard BE, Junien JL. The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia. Neurochemistry International. 28: 509-21. PMID 8792332 DOI: 10.1016/0197-0186(95)00144-1  0.244
1995 Maginn M, Caldwell M, Neill MJO, Kelly JP, Leonard BE. Metabotropic And Ionotropic Receptor Antagonists Prevent The Neurodegeneration Seen Following 5 Min Bilateral Carotid Occlusion In The Mongolian Gerbil Model Of Cerebral Ischaemia Behavioural Pharmacology. 6: 625. DOI: 10.1097/00008877-199508000-00055  0.244
2006 Leonard BE. Depression and brain dysfunction. Edited by Gilliam et al. Taylor & Francis. Pages: 297 + xxii. ISBN: 1-84214-214-3 Human Psychopharmacology-Clinical and Experimental. 21: 489-490. DOI: 10.1002/Hup.797  0.243
1978 Earley CJ, Leonard BE. GABA and gonadal hormones. Brain Research. 155: 27-34. PMID 688014 DOI: 10.1016/0006-8993(78)90302-5  0.242
1993 Leonard B. Brain function and psychotropic drugs. Ashton Heather. Oxford: Oxford University Press, 1992. 436pp, £25.00. Irish Journal of Psychological Medicine. 10: 170-170. DOI: 10.1017/S0790966700012714  0.242
2017 Fountoulakis KN, Gonda X, Siamouli M, Moutou K, Nitsa Z, Leonard BE, Kasper S. Higher than recommended dosages of antipsychotics in male patients with schizophrenia are associated with increased depression but no major neurocognitive side effects: Results of a cross-sectional pilot naturalistic study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28137432 DOI: 10.1016/J.Pnpbp.2017.01.013  0.242
1993 Leonard BE. Novel antipsychotic drugs: Edited by H.Y. Meltzer. ISBN 0-88167-893-7 Price: US$ 112.50. Raven Press, New York (1992) Neurochemistry International. 22: 599. DOI: 10.1016/0197-0186(93)90035-4  0.241
1996 Allain H, Reymann JM, O’Neill M, Caldwell M, Leonard BE, Bentué-Ferrer D. Neuroprotective effects of dopamine receptors agonists in cerebral ischemia European Neuropsychopharmacology. 6: 76. DOI: 10.1016/0924-977X(96)87649-8  0.241
1993 Leonard BE. Animal Models of Drug Addiction (Neuromethods 24): Edited by Alan A. Boulton, Glen B. Baker and Peter H. Wu. ISBN0-89603-217-5. Published by Humana Press, New Jersey, U.S.A. 1992. pp. 436+xxii. Price U.S. $104 Neurochemistry International. 23: 595. DOI: 10.1016/0197-0186(93)90108-H  0.239
2005 Leonard BE. Is there an immunologic basis for schizophrenia? Expert Review of Clinical Immunology. 1: 103-12. PMID 20477658 DOI: 10.1586/1744666X.1.1.103  0.239
1989 Moran P, Leonard BE. Noradrenaline and animal cognitive processes: implications for dementia Irish Journal of Psychological Medicine. 6: 106-108. DOI: 10.1017/S079096670001541X  0.239
2006 Leonard BE. Handbook of Psychiatric Drugs. Edited by Jeffrey A, Leberman and Allan Tasman. John Wiley & Sons Ltd, Chichester, UK, 2006. ISBN‐13:978‐0‐470‐02821‐6 Human Psychopharmacology-Clinical and Experimental. 21: 491-492. DOI: 10.1002/Hup.788  0.238
2004 Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, Leonard BE. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 1129-34. PMID 15610925 DOI: 10.1016/j.pnpbp.2004.05.047  0.238
1997 O'Connell AW, Strada O, Earley B, Leonard BE. Altered expression of amyloid protein precursor mRNA in the rat hippocampus following trimethyltin intoxication: an in situ hybridization study. Neurochemistry International. 30: 313-20. PMID 9041563 DOI: 10.1016/S0197-0186(96)00052-6  0.237
1984 Corbett R, Leonard BE. Effects of carnitine on changes caused by chronic administration of alcohol. Neuropharmacology. 23: 269-71. PMID 6143279 DOI: 10.1016/0028-3908(84)90069-8  0.237
1974 Leonard BE. Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain Psychopharmacologia. 36: 221-236. PMID 4846327 DOI: 10.1007/BF00421804  0.236
1998 Leonard BE. Book review: Stress, Stress Hormones and the Immune System. Edited by: Julia C. Buckingham, Glanda E. Gillies and Anne‐Marie Cowell. Published by John Wiley & Sons, Chichester, U.K. ISBN: 0‐471‐95886‐7, 412 pp., 1997. Price: £60. Human Psychopharmacology-Clinical and Experimental. 13: 299-300. DOI: 10.1002/(Sici)1099-1077(199806)13:4<299::Aid-Hup998>3.0.Co;2-I  0.236
1984 Leonard BE. The olfactory bulbectomized rat as a model of depression. Polish Journal of Pharmacology and Pharmacy. 36: 561-9. PMID 6099892  0.236
1978 Earley CJ, Leonard BE. Isolation and assay of noradrenaline, dopamine, 5-hydroxy-tryptamine, and several metabolites from brain tissue using disposable bio-rad columns packed with sephadex G-10 Journal of Pharmacological Methods. 1: 67-79. DOI: 10.1016/0160-5402(78)90010-4  0.235
1978 Lynch MA, Leonard BE. Effect of chronic amphetamine administration on the behaviour of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants. The Journal of Pharmacy and Pharmacology. 30: 798-9. PMID 32250 DOI: 10.1111/j.2042-7158.1978.tb13398.x  0.234
1977 Earley CJ, Leonard BE. The effect of testosterone and cyproterone acetate on the concentration of γ-aminobutyric acid in brain areas of aggressive and non-aggressive mice Pharmacology, Biochemistry and Behavior. 6: 409-413. PMID 560698 DOI: 10.1016/0091-3057(77)90177-0  0.234
2004 Kim YK, Myint AM, Han CS, Steinbusch HWM, Maes M, Leonard BE. P.1.007 Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)80096-8  0.232
1996 Noonan D, O'Mahony S, Leonard BE. The Effects Of The Sigma Ligand Jo-1784 Administartion On Superoxide Dismutase Activity In The Rodent Brain After Tmt Intoxication Biochemical Society Transactions. 24. DOI: 10.1042/Bst024542Sa  0.232
1999 Leonard BE. Movement disorders and abuse potential of the selective serotonin reuptake inhibitors Human Psychopharmacology. 14: 1-6. DOI: 10.1002/(SICI)1099-1077(199901)14:1<1::AID-HUP38>3.0.CO;2-L  0.232
2004 Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, Steinbusch HW. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Research. 129: 267-72. PMID 15661320 DOI: 10.1016/j.psychres.2004.08.005  0.231
2004 Leonard BE. A Companion to the Concise Guide to Drug Interaction Principles for Medical Practice. 2nd edition. Edited by K. L. Cozza, S. C. Armstrong and J. R. Oesterheld. American Psychiatric Publishing Inc: Washington, DC, 2003. Pages: 525. ISBN: 1-58562-111-0. Human Psychopharmacology-Clinical and Experimental. 19: 435-435. DOI: 10.1002/Hup.607  0.23
2004 Leonard BE. Pharmacogenetics of Psychotropic Drugs. Edited by Bernard Lerer. Cambridge University Press: Cambridge, 2003. Pages: 446. ISBN 0‐521‐80617‐8. Price £95 Human Psychopharmacology-Clinical and Experimental. 19: 590-590. DOI: 10.1002/Hup.520  0.23
2003 Leonard BE. Molecular Biology of Drug Addiction. Edited by R. Moldonado. Humana Press: Totowa, 2002. Pages 346. ISBN: 1-58829-060-3. Price $135 Human Psychopharmacology-Clinical and Experimental. 18: 580-582. DOI: 10.1002/Hup.527  0.23
1996 Leonard BE. Book Review. Alcohol, Drugs of Abuse and Immune Functions Human Psychopharmacology-Clinical and Experimental. 11: 427-427. DOI: 10.1002/(Sici)1099-1077(199609)11:5<427::Aid-Hup811>3.0.Co;2-M  0.23
1975 Leonard BE. Changes in rat brain monoamine metabolism following the acute administration of lithium chloride in combination with antidepressant drugs Archives Internationales De Pharmacodynamie Et De Therapie. 215: 202-207. PMID 1164088  0.229
1999 Leonard BE. Stress, Immune Function and Health: The Connection. by Bruce S. Rubin, Wiley‐Liss, New York, 1999. £58.50. ISBN: 0‐471‐2418104. Human Psychopharmacology-Clinical and Experimental. 14: 515-516. DOI: 10.1002/(Sici)1099-1077(199910)14:7<515::Aid-Hup138>3.0.Co;2-C  0.229
2001 Leonard BE. Pharmacotherapy for mood, anxiety and cognitive disorders. Edited by Halbreich U and Montgomery S, American Psychiatric Press Inc. Pages: 804 + xxii. ISBN: 0-88048-885-9. Price: 63.50. Human Psychopharmacology-Clinical and Experimental. 16: 487-487. DOI: 10.1002/Hup.302  0.229
2007 Bushe CJ, Leonard BE. Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials. The Journal of Clinical Psychiatry. 68: 1682-90. PMID 18052561 DOI: 10.4088/Jcp.V68N1107  0.229
1989 Leonard BE. The flower of paradise: The institutionalized use of the drug QAT in North Yemen. John G. Kennedy. Published by D. Reidel. Publishing Co. 1987. ISBN 1‐nn55608‐011‐5 Human Psychopharmacology-Clinical and Experimental. 4: 73-74. DOI: 10.1002/Hup.470040115  0.229
1993 Leonard B. Handbook of psychiatric drugs Lisa Burwell-Sipes. Newport Beach: Current Clinical Strategies, 1993. 80pp, £5.50. Irish Journal of Psychological Medicine. 10: 170-170. DOI: 10.1017/S0790966700012726  0.229
2003 Shu SY, Wu YM, Bao XM, Leonard B. Interactions among memory-related centers in the brain Journal of Neuroscience Research. 71: 609-616. PMID 12584720 DOI: 10.1002/jnr.10545  0.228
2017 Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatrica. 1-16. PMID 28112061 DOI: 10.1017/neu.2016.69  0.227
2001 Leonard BE. Commentary on the nature and treatment of bipolar disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 2: 110-3. PMID 12587195 DOI: 10.3109/15622970109026798  0.227
1995 O'Neill M, Allain H, Bentué-Ferrer D, Bellissant E, de Certaines J, Leonard BE. Pharmacological strategies in the treatment of cerebral ischemia. European Neurology. 35: 28-36. PMID 8529727 DOI: 10.1159/000119496  0.227
2002 Leonard BE. Drug induced neurological disorders. (2nd revised edition). K. K. Jain. Hofgrefe and Haber: Goettingen, 2001. ISBN: 0‐88937‐219‐5. Price DM 148. Pages 474. Human Psychopharmacology-Clinical and Experimental. 17: 314-314. DOI: 10.1002/Hup.416  0.227
1996 Caldwell M, O'Neill M, Earley B, Leonard BE. N(G)-Nitro-L-arginine-methyl-ester protects against ischaemia-induced biochemical changes and hippocampal neurodegeneration in the gerbil Human Psychopharmacology. 11: 299-307. DOI: 10.1002/(SICI)1099-1077(199607)11:4<299::AID-HUP772>3.0.CO;2-E  0.227
1979 Earley CJ, Leonard BE. Androgens, estrogens and their anti-hormones: effects on body weight and food consumption. Pharmacology, Biochemistry, and Behavior. 11: 211-4. PMID 504300 DOI: 10.1016/0091-3057(79)90015-7  0.226
1996 Leonard BE. Litigation and the toxicity of psychotropic drugs: A reply to Prof Patricia Casey Irish Journal of Psychological Medicine. 13: 170-171. DOI: 10.1017/S079096670000450X  0.226
1996 Leonard BE. Litigation and the toxicity of psychotropic drugs Irish Journal of Psychological Medicine. 13: 88-89. DOI: 10.1017/S0790966700002585  0.225
1987 Leonard BE. Stress, the immune system and mental illness Stress Medicine. 3: 257-258. DOI: 10.1002/Smi.2460030403  0.225
1988 Leonard BE. Alcohol as a social teratogen. Progress in Brain Research. 73: 305-17. PMID 2901777 DOI: 10.1016/S0079-6123(08)60512-9  0.225
1991 Leonard BE, Everitt B. CCK and anxiety. Journal of Psychopharmacology (Oxford, England). 5: 439-40. PMID 22282856 DOI: 10.1177/026988119100500441  0.224
2003 Leonard BE. Fatty acids: physiological and behavioural functions. Edited by D. I. Mostofsky, S. Yehuda and N. Salem. Humana Press: New Jersey, 2001. Pages: 435. ISBN: 0‐86903‐942‐0. Human Psychopharmacology-Clinical and Experimental. 18: 317-317. DOI: 10.1002/Hup.485  0.224
1990 Leonard BE. Neurotransmitters, drugs and disease. Edited by R. A. WEBSTER and C. C. JORDAN. Blackwell Scientific Publications, Edinburgh, 1989. Pages 474. Price £19.50. ISBN 0–632–00717–6 Human Psychopharmacology-Clinical and Experimental. 5: 258-258. DOI: 10.1002/Hup.470050316  0.223
2013 Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology (Oxford, England). 27: 967-71. PMID 24067791 DOI: 10.1177/0269881113503509  0.223
2005 Leonard BE. Clinical Handbook of Psychotropic Drugs. Edited by K. Bezchlibnyk‐Butler and J. J. Jeffries. Hogrefe and Huber: Ashland, OH, USA, 2005. 15th edn. Pages: 344. ISBN: 0‐88937‐293‐4 Human Psychopharmacology-Clinical and Experimental. 20: 596-596. DOI: 10.1002/Hup.724  0.223
1976 Leonard BE. Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain Psychopharmacologia. 46: 11-18. PMID 1257360 DOI: 10.1007/BF00421543  0.223
2003 Leonard BE. Perspectives in affective disorders. Edited by W.P. Kaschka Karger: Basel, 2002. ISBN 3‐8055‐7439‐8. Price $163.50 £134.50 CHF 188.00. Pages 204. Human Psychopharmacology-Clinical and Experimental. 18: 413-413. DOI: 10.1002/Hup.499  0.222
2008 Leonard BE. Serotonin and Sleep: Molecular, Functional and Clinical Aspects. Edited by J. M. Monti, S. R. Pandi‐Perumal, B. L. Jacobs and D. J. Nutt. Published by Birkhaeuser, Basel. 2008. ISBN 978‐3‐7643‐8560‐6 (hardback). Price Euro 170, pp. 621 Human Psychopharmacology-Clinical and Experimental. 23: 538-539. DOI: 10.1002/Hup.953  0.222
2004 Leonard BE. Clinical Handbook of Psychotropic Drugs (13th Edition). Edited by Kalyna Z. Bezchlibuyle-Butler and J. Joel Jeffries. Hogrefe and Huber: USA, 2003. ISBN 0-88937-273-x Human Psychopharmacology-Clinical and Experimental. 19: 69-69. DOI: 10.1002/Hup.545  0.222
1989 Leonard BE. The benzodiazepine receptor, by WALTER E. MÜLLER, Cambridge University Press, London, 1987. ISBN 0‐521‐30418‐0. price £27.50 Human Psychopharmacology-Clinical and Experimental. 4: 229-230. DOI: 10.1002/Hup.470040309  0.221
2009 Leonard BE. Stress: The brain‐body connection. Edited by D.H. Hellhammer, J. Hellhammer. Karger, Basel 2008. ISBN‐978‐3‐8055‐8295‐7. pages: 173 Human Psychopharmacology-Clinical and Experimental. 24: 153-153. DOI: 10.1002/Hup.995  0.221
1994 Ryan PM, Kelly JR, Leonard BE, Chambers PL. Acute toxicity testing of lofepramine, in a non lethal dose range Toxicology Letters. 74: 70. DOI: 10.1016/0378-4274(94)90400-6  0.221
2003 Leonard BE. Manual of Psychiatric Therapeutics. Edited by R. I. Shader. 3rd Edition. Lippincott Williams and Wilkins: Philadelphia, 2003. Pages: 528. ISBN 0‐7817‐2470‐8. Price $39.95 Human Psychopharmacology-Clinical and Experimental. 18: 579-580. DOI: 10.1002/Hup.517  0.221
2006 Leonard BE. Drug interactions in psychiatry (3rd Edn). Edited by D. C. Ciraulo, R. I. Shader, D. J. Greenblatt and W. Creelman. Lippincott, Williams and Wilkins: Philadelphia, 2006. ISBN: 0‐7817‐4817‐8. Pages: 450 Human Psychopharmacology-Clinical and Experimental. 21: 205-206. DOI: 10.1002/Hup.756  0.22
2004 Leonard BE. Antidepressants: Past, Present and Future. Edited by Seldon H. Preskorn, John P. Feighner, Christina Y. Stanga and Ruth Ross. Springer Verlag: Berlin, 2004. ISBN 3‐540‐43054‐7 Human Psychopharmacology-Clinical and Experimental. 19: 587-587. DOI: 10.1002/Hup.641  0.22
2001 Leonard BE. How the brain talks to itself – a clinical primer of psychotherapeutic neuroscience. Edited by J. E. Harris, The Haworth Press, 1998. Pages: 428. ISBN: 0‐7890‐0409‐7 Human Psychopharmacology-Clinical and Experimental. 16: 282-283. DOI: 10.1002/Hup.249  0.22
2004 Leonard BE. Quick Reference Guide to the APA Practice Guidelines for the Treatment of Psychiatric Disorders—Compendium 2002. Edited by M. B. First. American Psychiatric Association: Washington, DC. ISBN 0‐89042‐321‐0 Human Psychopharmacology-Clinical and Experimental. 19: 68-69. DOI: 10.1002/Hup.546  0.22
1992 Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs. 43: 3-9; discussion 9-10. PMID 1378371 DOI: 10.2165/00003495-199200432-00003  0.22
2008 Leonard BE. Performance enhancing medications and drugs of abuse. Edited by Mark S. Gold. The Hawarth Medical Press Inc., New York 2007. ISBN 10:0‐7890‐3665‐7 (paperback). pp. 64 Human Psychopharmacology-Clinical and Experimental. 23: 341-342. DOI: 10.1002/Hup.938  0.219
2001 Leonard BE. Central nervous system diseases: innovative animal models from lab to clinic Human Psychopharmacology-Clinical and Experimental. 16: 357-358. DOI: 10.1002/Hup.253  0.219
2005 Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. European Psychiatry : the Journal of the Association of European Psychiatrists. 20: S302-6. PMID 16459240 DOI: 10.1016/S0924-9338(05)80180-4  0.218
2006 Leonard BE. Handbook of psychiatric drug therapy. Edited by I. F. Rosenbaum, G. W. Arana, S. E. Hyman and L. A. Labbate. Lippincott, Williams & Wilkins: Philadelphia, 2005. Pages: 322. ISBN 0‐7817‐5188‐8 Human Psychopharmacology-Clinical and Experimental. 21: 273-273. DOI: 10.1002/Hup.768  0.218
2004 Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Human Psychopharmacology. 19: 151-80. PMID 15079851 DOI: 10.1002/hup.579  0.218
2010 Leonard BE. Clinical Handbook of Psychotropic Drugs Edited by A. S. Virani, K. Z. Bezchlibynk-Butler, J. J. Jeffries. Hogrefe and Huber Gmbh, Goettingen, Germany 2009. ISBN 0-88937-369-8 pp. 372 Human Psychopharmacology-Clinical and Experimental. 25: 92-92. DOI: 10.1002/Hup.1079  0.218
1987 Leonard BE. Encyclopedia of psychoactive Drugs. Snyder, S. H., and Lader, M. H. (General editors). London: Burke, 1985 Human Psychopharmacology-Clinical and Experimental. 2: 247-248. DOI: 10.1002/Hup.470020409  0.218
1979 Leonard BE. Pharmacological and biochemical aspects of hyperkinetic disorders. Neuropharmacology. 18: 923-9. PMID 43483 DOI: 10.1016/0028-3908(79)90156-4  0.217
2003 Shu SY, Bao XM, Ning Q, Wu YM, Wang J, Leonard BE. New component of the limbic system: Marginal division of the neostriatum that links the limbic system to the basal nucleus of Meynert. Journal of Neuroscience Research. 71: 751-7. PMID 12584733 DOI: 10.1002/jnr.10518  0.217
2019 Jenkins R, Ong'echa M, Othieno C, Ongeri L, Sifuna P, Omollo R, Leonard B, Ogutu B. Malaria, mental disorders, immunity and their inter-relationships - A cross sectional study in a household population in a health and demographic surveillance site in Kenya. Ebiomedicine. 39: 369-376. PMID 30552065 DOI: 10.1016/j.ebiom.2018.11.064  0.217
2010 Leonard BE. Clinical trials in Psychopharmacology: A better brain, (2nd edn). Edited by Hertzman Marc and Adler Lawrence. Wiley‐Blackwell, Chichester, UK, 2010. pp. 404. ISBN: 978‐0‐470‐74076‐7. Human Psychopharmacology-Clinical and Experimental. 25: 588-589. DOI: 10.1002/Hup.1151  0.216
1987 Leonard BE. The endocoids(Progress in Clinical and Biological Research, Vol. 192). Edited by H. Lal, F. LaBella and J. Lane. ISBN 0-8451-5042-1. Price: $78. Alan R. Liss, Inc., New York, 1985. Neurochemistry International. 10: 245-246. DOI: 10.1016/0197-0186(87)90135-5  0.216
2008 Leonard BE. Pharmacology of bipolar disorders. Edited by J. M. Aubry, F. Ferrero, N. Schaad. John Wiley & Sons (2007). ISBN‐ 978‐0‐470‐05823‐7 pp. 277 Human Psychopharmacology-Clinical and Experimental. 23: 723-723. DOI: 10.1002/Hup.981  0.216
1999 Leonard BE. Marihuana and Medicine. Edited by G. G. Nahas, K. M. Sutin, D. Harvey and S. Agurell. Co‐editors N. Pace and R. Cancro. Humana Press, New Jersey, 1999. ISBN: 0‐89603‐593‐X. $125.00. Human Psychopharmacology-Clinical and Experimental. 14: 516-517. DOI: 10.1002/(Sici)1099-1077(199910)14:7<516::Aid-Hup137>3.0.Co;2-C  0.216
2002 Leonard BE. Principles and practice of psychopharmacology. (Third Edition). P. G. Janicak, J. M. Davis, S. H. Preskorn and F. J. Ayd. Lippincott, Williams and Williams: Philadelphia, 2001. Pages: 720. ISBN: 0-7817-2794-4. Price $120.00 Human Psychopharmacology-Clinical and Experimental. 17: 167-168. DOI: 10.1002/Hup.382  0.214
2004 Leonard BE. Cognitive Enhancing Drugs. Edited by J. J. Buccafusco. Birkhauser Verlag: Berlin. Pages: 215. ISBN: 3-7643-6982-5. Price CHF 198/ Euros 128 Human Psychopharmacology-Clinical and Experimental. 19: 359-360. DOI: 10.1002/Hup.603  0.214
1977 Leonard BE. Some effects of mianserine (ORG GB 94) on amine metabolism in the rat brain Pharmakopsychiatrie Und Neuropsychopharmakologie. 10: 92-95. PMID 616924  0.214
2001 Leonard BE. Current Issues in the Psychopharmacology of Schizophrenia. Edited by A. Breier, P. V. Tran, J. M. Herrera, G. D. Tollefson and F. P. Bymaster. Lippincott Williams and Wilkins, Philadelphia, 2001. ISBN 07817‐2422‐8. Price $39.95. Human Psychopharmacology-Clinical and Experimental. 16: 545-546. DOI: 10.1002/Hup.330  0.214
1994 Leonard BE. The enigma of sigma receptors European Neuropsychopharmacology. 4: 174-175. DOI: 10.1016/0924-977X(94)90020-5  0.214
1987 Leonard BE. Alcohol and the developing brain. Edited by V. Rydberg, C. Alling, J. Engel, B. Pernow, L. A. Pellborn and S. Rössner. Raven Press, New York, 1985. pp. 239. $61.50. Human Psychopharmacology-Clinical and Experimental. 2: 57-58. DOI: 10.1002/Hup.470020119  0.214
1998 Darcy P, Kelly JP, Leonard BE, Chambers PL. An evaluation of the acute toxicity of antidepressants using mortality data, literature LD50 values, and the TOPKAT™ programme Toxicology Letters. 95: 77. DOI: 10.1016/S0378-4274(98)80304-4  0.214
2003 Leonard BE. Textbook of biological psychiatry (2 vol set). Edited by H. D'haenen, H. den Boer and P. Willner. John Wiley & Sons: Chichester, 2002. Pages: 1450. ISBN 0471‐491 985. Price £350 Human Psychopharmacology-Clinical and Experimental. 18: 151-152. DOI: 10.1002/Hup.450  0.213
2010 Leonard BE. Pleasures of the Brain Edited by Morten L. Kringelbach, Kent C. Berridge, Oxford University Press, Oxford. pp 343, ISBN: 978-0- 533102-8 Human Psychopharmacology-Clinical and Experimental. 25: 429-429. DOI: 10.1002/Hup.1123  0.212
2002 Leonard BE. The Psychopharmacology of Herbal Medicines. Marcello Spinella. MIT Press, UK, 2000. Pages: 578. ISBN: 0‐262‐69265‐1. Price: £16.95 Human Psychopharmacology-Clinical and Experimental. 17: 65-65. DOI: 10.1002/Hup.341  0.212
1994 Leonard BE, Nicholson CD. Sigma ligands as potential psychotropic drugs. Journal of Psychopharmacology (Oxford, England). 8: 64-5. PMID 22298484 DOI: 10.1177/026988119400800112  0.212
1989 Leonard B. Perspectives in Psychopharmacology. A Collection of Papers in Honour of Earl Usdin: Edited by J. D. Barchas and W. E. Bunney. ISBN 0 8451 2742 X. Price: $118. Alan R. Liss, New York, 1988 Neurochemistry International. 14: 105-106. DOI: 10.1016/0197-0186(89)90023-5  0.212
2010 Leonard BE. Biological psychiatry: Third edition. Michael R. Trimble, and Mark S. George. Wiley-Blackwell, Chichester, UK, 2010, pp. 406 ISBN: 978-0-470-68894-6 Human Psychopharmacology-Clinical and Experimental. 25: 589-590. DOI: 10.1002/Hup.1178  0.211
2004 Bushe C, Leonard B. Association between atypical antipsychotic agents and type 2 diabetes: Review of prospective clinical data British Journal of Psychiatry. 184: s87-s93. PMID 15056600 DOI: 10.1192/bjp.184.47.s87  0.211
2006 Leonard BE. Cannabis dependence: its nature, consequences and treatment. Edited by R. A. Roffman and R. Stephens. Cambridge University Press, 2006. ISBN-10-0-521-81447-2 pp 371 Human Psychopharmacology-Clinical and Experimental. 21: 414-414. DOI: 10.1002/Hup.784  0.211
1991 Leonard BE. Schizophrenia Research (Advances in Neuropsychiatry and Psychopharmacology, Vol. 1): Edited by Carol A. Tamminga and S. Charles Schulz. ISBN RC 514.533635, Price $150, Raven Press, New York, 1991 Neurochemistry International. 19: 384-385. DOI: 10.1016/0197-0186(91)90026-A  0.21
2003 Leonard BE. Principles and practice of psychopharmacotherapy. 3rd edition. P. G. Janicak, J. M. Davis, S. H. Preskorn and F. J. Ayd. Lippincott Williams and Wilkins: Philadelphia, 2001. Pages: 700. ISBN: 0‐7817‐2794‐4 Human Psychopharmacology-Clinical and Experimental. 18: 317-318. DOI: 10.1002/Hup.486  0.21
2005 Leonard BE. Mind Over Matter: Regulation of Peripheral Inflammation by the CNS. Edited by M. Schäfer and C. Stein. Birkhauser: Boston, 2004. Pages: 204. ISBN: 3-7643-6918-3 Human Psychopharmacology-Clinical and Experimental. 20: 71-72. DOI: 10.1002/Hup.656  0.209
2005 Leonard BE. Neurological and Psychiatric Disorders from Bench to Bedside. Edited by F. I. Tarazi and J. A. Schetz. Humana Press: Totowa, NJ, 2004. Pages: 263. ISBN 1-58829-369-6 Human Psychopharmacology-Clinical and Experimental. 20: 295-295. DOI: 10.1002/Hup.690  0.209
1986 O'Neill B, Leonard BE. Is there an abnormality in neutrophil phagocytosis in depression? Ircs Medical Science. 14: 802-803.  0.209
2006 Leonard BE. Atypical antipsychotics—from bench to bedside. Edited by John G. Csernansky and John Lauriello. Published by Marcel Dekker Inc. New York, 2004. ISBN 0‐8247‐5412‐3 Human Psychopharmacology-Clinical and Experimental. 21: 490-491. DOI: 10.1002/Hup.787  0.209
2001 Leonard BE. The molecular biology of cytokines. Edited by Tony Meagher, John Wiley and Sons, 1998. ISBN: 0‐471‐98272‐5 Human Psychopharmacology-Clinical and Experimental. 16: 195-196. DOI: 10.1002/Hup.244  0.209
2004 Leonard BE. SSRIs, aggression and suicide - a cause for concern or the result of media hype? Irish Journal of Psychological Medicine. 21: 40-42. PMID 30308763 DOI: 10.1017/S0790966700008247  0.208
2001 Leonard BE. Neurosteroids: a new regulatory function in the nervous system Human Psychopharmacology-Clinical and Experimental. 16: 358-359. DOI: 10.1002/Hup.254  0.208
1990 Leonard BE. Synaptic function. Edited by Gerald M. Edelman, W. Winar Gall and W. Maxwell Cowan. A Neuroscience Institute Publication. John Wiley and Sons, New York, 1987. ISBN 0–471–63708–4. price £40.90 Human Psychopharmacology-Clinical and Experimental. 5: 64-65. DOI: 10.1002/Hup.470050111  0.208
2004 Leonard BE. Biochemical Basis of Neuropharmacology (8th Edition). J. R. Cooper, F. E. Bloom and R. H. Roth. Oxford University Press: Oxford, 2002. ISBN 0‐19‐514007‐9 Human Psychopharmacology-Clinical and Experimental. 19: 67-67. DOI: 10.1002/Hup.553  0.207
2008 Leonard BE. Glial Neurobiology. Alexei Verkhratsky and Arthur Butt. John Wiley and Sons Ltd., Chichester, UK (2007). ISBN 978‐0‐470‐51740‐6, pp. 215 paperback. Human Psychopharmacology-Clinical and Experimental. 23: 537-538. DOI: 10.1002/Hup.954  0.207
1998 Leonard BE. Book review: Handbook of Essential Fatty Acid Biology. Edited by Shlomo Yehuda and David A. Mostofsky. Human Press, New Jersey, 1997. 470 pp. $145. ISBN 0‐89603‐365‐1. Human Psychopharmacology-Clinical and Experimental. 13: 68-69. DOI: 10.1002/(Sici)1099-1077(199801)13:1<68::Aid-Hup959>3.0.Co;2-0  0.207
2001 Leonard BE. The Maudsley 2001 prescribing guidelines (Sixth edition). D. Taylor, H. McConnell, D. McConnell and R. Kerwin. Martin Dunitz Ltd, London, 2001. ISBN: 1-85317-963-9. Price: £14.95. Human Psychopharmacology-Clinical and Experimental. 16: 431-431. DOI: 10.1002/Hup.313  0.207
2008 Leonard BE. Psychiatric disorders and diabetes mellitus. Edited by M.D. Lloreute and J.E. Malphurs, Informo Healthcare, Thompson Publishing Services: Andover, Hants, UK, 2007. Pages: 340. ISBN 13-978-0-415-385411 Human Psychopharmacology-Clinical and Experimental. 23: 68-70. DOI: 10.1002/Hup.894  0.207
2000 Leonard BE. Evidence for a biochemical lesion in depression. The Journal of Clinical Psychiatry. 61: 12-7. PMID 10775019  0.207
1991 Boyle C, Sheppard BL, Bonnar J, Jordan M, Norris LA, Sharma SC, McKone E, Gleeson N, Quigley J, Gonsalves R, McGuinness E, Rowan MJ, Penney L, Anwyl R, O’Mahony D, ... ... Leonard BE, et al. Royal Academy of Medicine in Ireland Section of Biological Sciences Proceedings of Winter Meeting at Earlsfort Terrace, University College Dublin, 4th January 1991 Irish Journal of Medical Science. 160: 358-372. DOI: 10.1007/Bf02957896  0.206
2004 Leonard BE. Psychopharmacology: An Introduction (4th Edition). R. Spiegel. John Wiley & Sons: Chichester, 2003. ISBN 0‐471‐56039‐1 Human Psychopharmacology-Clinical and Experimental. 19: 67-68. DOI: 10.1002/Hup.548  0.206
2005 Leonard BE. Evidence Based Psychopharmacology. Edited by Dan Stein, Bernard Lerer, Stephen Stahl. Cambridge University Press, 2005. Pages: 380. ISBN‐0521531888 Human Psychopharmacology-Clinical and Experimental. 20: 597-597. DOI: 10.1002/Hup.737  0.206
2003 Leonard BE. Brain injury and mental retardation: psychopharmacology and neuropsychiatry. C. Thomas Gualtiere. Lippincott Williams and Wilkins: Philadelphia, 2002. Pages: 509. ISBN 0‐7817‐3473‐8 Human Psychopharmacology-Clinical and Experimental. 18: 151-151. DOI: 10.1002/Hup.447  0.206
1989 Leonard BE. Excitatory amino acids and neurological disease, edited by DAVID LLodge, John Wiley and Sons, Chichester, 1988, ISBN 0 471 91662 5, price £35.50 Human Psychopharmacology-Clinical and Experimental. 4: 152-153. DOI: 10.1002/Hup.470040214  0.206
1993 Leonard BE. Aluminium in biology and medicine (CIBA Foundation symposium 169) . Chichester: John Wiley and Sons, 1992. 326pp, £42.50. Irish Journal of Psychological Medicine. 10: 171-172. DOI: 10.1017/S0790966700012763  0.205
2003 Kelliher P, Kelly JP, Leonard BE, Sánchez C. Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test. Psychoneuroendocrinology. 28: 332-47. PMID 12573300 DOI: 10.1016/S0306-4530(02)00026-4  0.205
2001 Leonard BE. The CGRP family: Calcitonin gene‐related peptide (CGRP) amylin and adrenomellullin. Edited by David Poyner, Ian Marshall and Susan D. Brain. Landes Bioscience, 2000. Pages: 261. ISBN: 1‐58706‐004‐3 Human Psychopharmacology-Clinical and Experimental. 16: 195-195. DOI: 10.1002/Hup.242  0.205
2005 Leonard BE. Clinical Handbook of Psychotropic Drugs for Children and Adolescents. K. Z. Bezchlibnyk‐Butler and A. S. Virini. Hofgrefe and Huber: Cambridge, MA, USA, 2004. ISBN‐0‐88937‐271‐3 Human Psychopharmacology-Clinical and Experimental. 20: 70-70. DOI: 10.1002/Hup.647  0.205
2005 Leonard BE. Neurobiology of Mental Illness (2nd edn.). Edited by Dennis Charney and Eric J. Nestler Oxford University Press, (pbk) published 2004. ISBN‐0‐19‐518980‐9 Human Psychopharmacology-Clinical and Experimental. 20: 598-598. DOI: 10.1002/Hup.738  0.204
1975 Leonard BE. Neurochemical and neuropharmacological aspects of depression International Review of Neurobiology. 357-387.  0.204
2009 Leonard BE. Introduction to Neuropsychopharmacology. Edited by Leslie Iversen, Susan P. Iversen, Floyd E. Bloom and Robert H. Roth. Oxford University Press, 2009. ISBN 978‐0‐19‐538053‐8. pp. 557 Human Psychopharmacology-Clinical and Experimental. 24: 591-592. DOI: 10.1002/Hup.1053  0.204
2002 Leonard BE. Psychiatry as a neuroscience. edited by J. J. Lopez-Ibor, W. Gaebel, M. Maj and N. Sartorius. John Wiley and Sons: Chichester, UK, 2002. ISBN 0-471-49656-1. Price £60.00. Pages 330. Human Psychopharmacology-Clinical and Experimental. 17: 313-314. DOI: 10.1002/Hup.410  0.204
2002 Leonard BE. Neuropsychopharmacology?The fifth generation of progress. Edited by K. L. Davis, D. Charney, J. T. Coyle, C. Nemeroff. Lippincott, Williams and Wilkins: Philadelphia, 2002. ISBN: 0-7817-2837-1. Price: $189. Pages: 2080 Human Psychopharmacology-Clinical and Experimental. 17: 433-433. DOI: 10.1002/Hup.431  0.203
1985 Daly L, Sheppard BL, Dockeray CJ, Bonnar J, Drudy L, Sharma SC, Hammad MK, Hourihan H, Yasear AY, Moore RE, Arbuthnott ER, Bolger C, Bannigan J, Deasy PB, Humphreys AJ, ... ... Leonard BE, et al. Royay academy of medicine in Ireland section of biological sciences - Proceedings of Winter Meeting, Department of Physiology, Trinity College, Dublin on Thursday, 3rd January, 1985 Irish Journal of Medical Science. 154: 318-334. DOI: 10.1007/Bf02937172  0.203
1996 Leonard BE. In search of black bile Irish Journal of Psychological Medicine. 13: 79-82. DOI: 10.1017/S0790966700002536  0.203
1988 Leonard B. Stress and breast cancer. Edited by Cary L. Cooper. Published by John Wiley and Sons. Chichester, U.K. 1988 ISBN 0471‐91744‐3 Stress Medicine. 4: 177-178. DOI: 10.1002/Smi.2460040311  0.203
1996 Leonard BE. New approaches to the treatment of depression. The Journal of Clinical Psychiatry. 57: 26-33. PMID 8636063  0.202
1991 Leonard BE. Human psychopharmacology: Measures and methods, vol. 1. Edited by I. Hindmarch and P. D. Stonier. John Wiley & Sons, Chichester, 1987. ISBN 0–471–91238–7 Human Psychopharmacology-Clinical and Experimental. 6: 75-76. DOI: 10.1002/Hup.470060114  0.202
2002 Leonard BE. International handbook of suicide and attempted suicide. N. Hawton and J. van Heeringen. Wiley: Chichester, 2001. Pages: 755. ISBN: 0‐471‐98367‐5. Price: £75.00 Human Psychopharmacology-Clinical and Experimental. 17: 165-165. DOI: 10.1002/Hup.383  0.202
2007 Leonard BE. Cytokines and the CNS, 2nd ed., R.M. Rausohoff, E.N. Benveniste (Eds.). CRC, Taylor and Francis, London (2006), Price: £79.99, ISBN: 0-8493-1622-7 Journal of Chemical Neuroanatomy. 34: 62-63. DOI: 10.1016/J.Jchemneu.2007.03.008  0.202
2002 Leonard BE. Comprehensive care of schizophrenia. Edited by J. A. Lieberman and R. M. Murray, Martin Dunitz: London, 2001. Pages: 374. ISBN: 1‐85317‐893‐4. Price £49.95 Human Psychopharmacology-Clinical and Experimental. 17: 166-167. DOI: 10.1002/Hup.385  0.201
1984 Kennelly P, Mulligan SC, Corrigan OI, Barrett C, Ryan MP, Lawlor P, Gilna P, Martin F, Molloy AG, Waddington JL, O’Boyle KM, Dundee JW, Halliday NJ, Loughran PG, Harper KW, ... ... Leonard BE, et al. Royal academy of medicine in Ireland Section of biological sciences: Proceedings of Winter Meeting held on 3rd January, 1984 Irish Journal of Medical Science. 153: 223-232. DOI: 10.1007/BF02943604  0.201
1994 Leonard BE. Aspects of Synaptic Transmission 2: Acetylcholine, Sigma Receptors, CCK and Eicosanoids, Neurotoxins: Edited by T. W. Stone. Published by Taylor and Francis, London. ISBN 07484 0063 X (1993). Price £45.00 Neurochemistry International. 24: 505-506. DOI: 10.1016/0197-0186(94)90098-1  0.201
1994 Doolan CM, Keenan AK, Costello CM, McQuaid K, O'Connor CM, Fitzgerald MX, Southey A, Ryan P, Kelly J, Leonard BE, Grace D, Fee JPH, Milligan KR, Brazil D, Clyne C, et al. Royal academy of medicine in Ireland section of biomedical sciences - Proceedings of Winter Meeting held 4th January 1994 at the Veterinary College, University College Dublin Irish Journal of Medical Science. 163: 258-268. DOI: 10.1007/Bf02943263  0.201
1997 Leonard BE. The role of noradrenaline in depression: a review. Journal of Psychopharmacology (Oxford, England). 11: S39-47. PMID 9438232  0.2
2001 Leonard BE. Alcohol and coffee use in the aging. Edited by R. R. Watson. Published by CRC Press, New York, 2001. ISBN: 0‐8493‐2257‐X. Human Psychopharmacology-Clinical and Experimental. 16: 431-432. DOI: 10.1002/Hup.314  0.2
2005 Leonard BE. Essential Psychopharmacology: The Prescriber's Guide. S. Stahl. Cambridge University Press: Cambridge, 2004. ISBN: 052 101 1698. Pages: 588 Human Psychopharmacology-Clinical and Experimental. 20: 449-449. DOI: 10.1002/Hup.701  0.199
2002 Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonard BE, Lieberman JA, López-Ibor JJ, Van Raay B, Twomey E, Kupfer DJ, Angst J, Cassano GB, Crow TJ, Freeman H, et al. The usefulness and use of second-generation antipsychotic medications: Preface Current Opinion in Psychiatry. 15: S1-S51. DOI: 10.1097/00001504-200203001-00001  0.199
2008 Leonard BE. Fundamentals of clinical psychopharmacology. Edited by Ian M. Anderson and Ian C. Reid. Informa Healthcare: Abingdon, Oxon, UK (2006). ISBN 13-978-0-415-39565-6, 190 pp Human Psychopharmacology-Clinical and Experimental. 23: 68-68. DOI: 10.1002/Hup.895  0.199
2001 Leonard BE. Neuropeptide Y protocols. Edited by A. Balasubramaniam. Humana Press, Totowa, New Jersey, 2000. Pages: 246. ISBN: 0‐89603‐662‐6. Human Psychopharmacology-Clinical and Experimental. 16: 487-488. DOI: 10.1002/Hup.293  0.199
1990 Leonard BE. Elements of molecular neurobiology. By C. U. M. Smith. John Wiley and Sons, Chichester, UK., 1989. pages 525. Paperback price £17.95. ISBN 0–471–92124–6 Human Psychopharmacology-Clinical and Experimental. 5: 257-258. DOI: 10.1002/Hup.470050315  0.199
2017 Leonard B, Kinsella A, O’Donoghue C, Farrell M, Mahon M. Policy drivers of farm succession and inheritance Land Use Policy. 61: 147-159. DOI: 10.1016/J.Landusepol.2016.09.006  0.199
2001 Leonard BE. Pharmaceuticals (4 vols)Edited by J. L. McGuire, John Wiley & Sons, 2000. ISBN: 3527298746. Price: 635.00. Human Psychopharmacology-Clinical and Experimental. 16: 486-487. DOI: 10.1002/Hup.319  0.199
1990 Leonard BE. Therapeutic risk: Perception, measurement, management, edited by D. BURLEY and W. H. W. INMAN. John Wiley & Sons, Chichester, 1988, 116pp. £10.50 ISBN 0471–91752‐4 Human Psychopharmacology-Clinical and Experimental. 5: 259-259. DOI: 10.1002/Hup.470050317  0.199
1971 Leonard BE. The effect of Δ1,6 tetrahydrocannabinol on biogenic amines and their amino acid precursors in the rat brain Pharmacological Research Communications. 3: 139-145. DOI: 10.1016/0031-6989(71)90045-2  0.198
2010 Leonard BE. Philosophy of Psychopharmacology. Edited by Dan J. Stein Cambridge University Press: Cambridge, UK, 2008. Pages: 210. ISBN: 9780521856522 Human Psychopharmacology-Clinical and Experimental. 25: 93-94. DOI: 10.1002/Hup.1080  0.198
1999 Leonard BE. Treatment Algorithms in Psychopharmacology. Edited by Jan Fawcett, Dan Stein and Kenneth O. Jobson. John Wiley and Sons, Chichester, UK. £60. ISBN: 0-471-98109-5. Human Psychopharmacology-Clinical and Experimental. 14: 516-516. DOI: 10.1002/(Sici)1099-1077(199910)14:7<516::Aid-Hup139>3.0.Co;2-6  0.198
2020 Demin KA, Lakstygal AM, Volgin AD, de Abreu MS, Genario R, Alpyshov ET, Serikuly N, Wang D, Wang J, Yan D, Wang M, Yang L, Hu G, Bytov M, Zabegalov KA, ... ... Leonard BE, et al. Cross-species analyses of intra-species behavioral differences in mammals and fish. Neuroscience. PMID 31931109 DOI: 10.1016/J.Neuroscience.2019.12.035  0.197
2001 Leonard BE. Lexicon of psychiatry, neurology and the neuroscience. Edited by F. J. Ayd Jr. Lippincott, Williams and Wilkins, 2000. Pages: 1104. ISBN: 0‐7817‐2468‐6. Price: $69.00. Human Psychopharmacology-Clinical and Experimental. 16: 429-429. DOI: 10.1002/Hup.294  0.197
1998 Leonard BE. Book Review: Patch‐Clamp Applications and Protocols—Neuromethods 26. Edited by Alan A. Boulton, Glen B. Baker and Wolfgang Walz. Humana Press, New Jersey, 1995, 316 pp. $89.50. Human Psychopharmacology-Clinical and Experimental. 13: 142-143. DOI: 10.1002/(Sici)1099-1077(199803)13:2<142::Aid-Hup975>3.0.Co;2-U  0.197
2009 Leonard BE. Advances in psychosomatic medicine: Edited by R. Balon. Vol. 29 Karger: Basel (2008) ISBN: 978-3-8055-8357-2 (HB) pp 172 Human Psychopharmacology-Clinical and Experimental. 24: 154-156. DOI: 10.1002/Hup.1003  0.197
1978 Leonard BE, Kenny M. Some neuropharmacological aspects of schizophrenia: a short review. Irish Journal of Medical Science. 147: 43-8. PMID 567632 DOI: 10.1007/BF02947903  0.195
2006 Leonard BE, Myint A. Changes in the immune system in depression and dementia: causal or coincidental effects? Dialogues in Clinical Neuroscience. 8: 163-74. PMID 16889103  0.195
1987 Leonard BE. The Cellular Structure of the Mammalian Nervous System: HaroldHillman, ISBN 0-85200 916X. Price: £69.75. MTP Press Ltd, Lancaster, U.K. Neurochemistry International. 11: 249-250. DOI: 10.1016/0197-0186(87)90020-9  0.195
1988 Leonard BE. Neurochemistry: Fundamentals and concepts. FERDINAND HUCHO. VCH Verlagsgesellschaft MBH, Weinheim. Federal Republic of Germany, 1986: ISBN 3–527–25989–9. DM63 Human Psychopharmacology-Clinical and Experimental. 3: 228-229. DOI: 10.1002/Hup.470030313  0.195
2001 Leonard BE. Immunological techniques made easy. Edited by Olivier Cocket, Jean‐Luc Teilland and Catherine Santes, John Wiley and Sons, 1998. ISBN: 0‐471‐97277‐0 Human Psychopharmacology-Clinical and Experimental. 16: 282-282. DOI: 10.1002/Hup.243  0.194
1995 Galligan E, Al-Assar O, McIntyre IA, McKeown SR, Hollywood MA, Thornbury KD, McHale NG, Keenan AK, Gierschik P, Nelson AA, McKenna PG, Barnett YA, Curran AK, O'Halloran KD, Bradford A, ... ... Leonard BE, et al. Royal academy of medicine in ireland section of biomedical sciences - Proceedings of winter meeting 1995 Irish Journal of Medical Science. 164: 311-319. DOI: 10.1007/Bf02967214  0.193
2017 Leonard BE. Major Depression as a Neuroprogressive Prelude to Dementia: What Is the Evidence? Modern Trends in Pharmacopsychiatry. 31: 56-66. PMID 28738351 DOI: 10.1159/000470807  0.193
1988 Leonard B. Lithium and the endocrine system: Edited by F.N. Johnson. ISBN 3-8055-4606-8. Price $132.00. Karger, Basel, 1988 Neurochemistry International. 13: 563-564. DOI: 10.1016/0197-0186(88)90089-7  0.193
1992 Leonard BE. Neurobiology of learning, emotion and affect . John MaddenIV, editor. New York: Raven Press, 1991. 368pp, $150. Irish Journal of Psychological Medicine. 9: 137-138. DOI: 10.1017/S0790966700013720  0.192
2001 Caldwell J, Leonard BE. An introduction to the 'enantiomer debate' Human Psychopharmacology. 16: S65. PMID 12404709 DOI: 10.1002/hup.340  0.192
1998 MacDonncha C, Watson AWS, Jakeman PM, Welsh LJ, McGrath S, Watson AWS, Ooi H, Brady HR, O’Regan RG, McLoughlin P, Cantillon D, Bradford A, Deacy C, Garrett M, Lowe AS, ... ... Leonard BE, ... ... Leonard BE, ... ... Leonard BE, ... ... Leonard BE, et al. Royal academy of medicine in Ireland section of biomedical sciences Irish Journal of Medical Science. 167: 51-63. DOI: 10.1007/Bf02937557  0.192
1992 McAdams C, Leonard BE. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients. International Clinical Psychopharmacology. 7: 81-5. PMID 1487625  0.192
2005 Leonard BE. The biochemistry of suicide. Crisis. 26: 153-5. PMID 16485839 DOI: 10.1027/0227-5910.26.4.153  0.191
1989 Leonard BE. Psychiatric pharmacosciences of children and adolescents. Edited by CHARLES POPPER. American Psychiatric Press, INC., Washington, DC, 1987. ISBN 0‐88048‐089hyphen;0. pages 160 Human Psychopharmacology-Clinical and Experimental. 4: 71-72. DOI: 10.1002/Hup.470040113  0.191
1982 Leonard BE. Phenolsulfotransferase in Mental Health Research: Edited by Merton Sandler and Earl Usdin. Published by MacMillan, London, 1981. Price (£22) ISBN 0-333-320166 Neurochemistry International. 4: 442-444. DOI: 10.1016/0197-0186(82)90091-2  0.191
1996 Leonard BE. Tricyclic antidepressants: Effective, cheap but are they safe? Journal of Psychopharmacology. 10: 35-38.  0.19
2003 Leonard BE. Neuropsychopharmacology. Edited by W. Fleischhaker and D. Brooks. Springer Verlag: Berlin, 2003. Pages 117. ISBN: 3‐211‐83903‐8. Price €89 Human Psychopharmacology-Clinical and Experimental. 18: 580-580. DOI: 10.1002/Hup.526  0.19
1988 Carmody E, Morrissey B, Hutchinson M, Martin EA, Gray WJ, Rosner MJ, Hawkins SA, Millar JHD, Patterson V, Byrnes D, Swallow M, Boyd K, Bates D, Cartlidge NEF, French JM, ... ... Leonard BE, et al. Irish Neurological Association Proceedings of the 23rd Annual Scientific Meeting of the Irish Neurological Association — Galway, 9th–10th October 1987 Irish Journal of Medical Science. 157: 277-282. DOI: 10.1007/Bf02948287  0.19
2005 Leonard BE. Book review for HUP‐Vedhara and Irwin. Human Psychoneuroimmunology. Edited by Vedhara & Kwin. Pages: 324. ISBN: 0‐19‐856884‐3 Human Psychopharmacology-Clinical and Experimental. 20: 595-595. DOI: 10.1002/Hup.722  0.189
1996 Leonard BE. Book Review. Managing Scientists — Leadership Strategies in Research and Development Human Psychopharmacology-Clinical and Experimental. 11: 526-526. DOI: 10.1002/(Sici)1099-1077(199611)11:6<526::Aid-Hup835>3.0.Co;2-A  0.189
1984 Leonard BE. Inter-relationship between neurotransmitters. Neuropharmacology. 23: 213-8. PMID 6143277 DOI: 10.1016/0028-3908(84)90062-5  0.189
2012 Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. European Archives of Psychiatry and Clinical Neuroscience. 262: 13-22. PMID 22083391 DOI: 10.1007/S00406-011-0274-7  0.188
1995 Leonard BE. Proteins, transmitters and synapses. By David G. Nicholls. Blackwell Scientific Publications, Oxford, 1994. pp. 253. £22.50. ISBN 0-632-03661-3 Human Psychopharmacology-Clinical and Experimental. 10: 249-250. DOI: 10.1002/Hup.470100323  0.188
1995 Kelly JP, Leonard BE. The contribution of pre-clinical drug evaluation in predicting the clinical profile of the selective serotonin reuptake inhibitor paroxetine Journal of Serotonin Research. 2: 27-46.  0.187
1984 Leonard BE. Neurotransmitter markers of depression. The Australian and New Zealand Journal of Psychiatry. 18: 307-12. PMID 6151835 DOI: 10.3109/00048678409158792  0.187
2011 Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 261: 207-45. PMID 22033583 DOI: 10.1007/S00406-011-0259-6  0.186
1966 Leonard BE. The effect of the chronic administration of barbitone sodium on pituitary-adrenal function in the rat Biochemical Pharmacology. 15: 263-268. PMID 4287846  0.186
1984 Leonard BE. GABA and endocrine regulation. Neurochemistry International. 6: 17-22. PMID 20488015 DOI: 10.1016/0197-0186(84)90021-4  0.185
1987 Leonard BE. Ethanol as a neurotoxin. Biochemical Pharmacology. 36: 2055-9. PMID 3300652 DOI: 10.1016/0006-2952(87)90129-8  0.185
2001 Leonard BE. Handbook of alcoholism. Edited by Zernig et al. CRC Press. Pages: 492. ISBN: 0-8493-7801-X. Price: £69.99. Human Psychopharmacology-Clinical and Experimental. 16: 430-430. DOI: 10.1002/Hup.296  0.185
2005 Leonard BE. Neuropeptide Y and Related Peptides. Edited by M. C. Michel. Springer Verlag: Heidelberg, 2004. Pages: 555+x. ISBN: 3‐540‐40581‐x Human Psychopharmacology-Clinical and Experimental. 20: 73-73. DOI: 10.1002/Hup.650  0.185
2006 Elenkov IJ, Chrousos GP, Leonard BE, Cutolo M, Straub RH, Bricou O, Taïeb O, Baubet T, Gal B, Guillevin L, Moro MR, Ball TM, Sepa A, Ludvigsson J, Bagnasco M, et al. Contents Vol. 13, 2006 Neuroimmunomodulation. 13: 383-384. DOI: 10.1159/000107648  0.183
1995 Leonard BE. Critique. The involvement of neuromediation in alcohol abuse and alcoholism. Neurochemistry International. 26: 343-6. PMID 7633326 DOI: 10.1016/0197-0186(94)00141-G  0.183
1985 Burke M, Leonard BE. Effects of naloxone on some behavioural and biochemical actions of dextropropoxyphene Ircs Medical Science. 13: 236-237.  0.183
1993 Morrissey M, Leonard BE. Tobacco and alcohol use among medical students: a preliminary survey of final year medical students at University College, Galway Irish Journal of Psychological Medicine. 10: 60-60. DOI: 10.1017/S0790966700013379  0.182
1984 Silvestrini B, Valeri P, Feighner JP, Beaumont G, Gringras M, Ankier SI, Pöldinger W, Carney PA, Healy D, Leonard BE, Gershon S, Himmelhoch JM, Schechtman K, Auchenbach R, Merwe TJvd, et al. Contents, Vol. 17, Supplement 2, 1984 Psychopathology. 17. DOI: 10.1159/000284087  0.182
1968 Leonard BE. The effect of the chronic administration of sodium barbitone on the exploratory behaviour of rats Journal of Pharmacy and Pharmacology. 20: 397-398. PMID 4385448  0.18
1967 Leonard BE. The effect of chronic administration of barbitone sodium on the behaviour of the rat Neuropharmacology. 6: 63-70. PMID 6031624  0.18
2001 Leonard BE. Stress, norepinephrine and depression. Journal of Psychiatry & Neuroscience : Jpn. 26: S11-6. PMID 11590964 DOI: 10.1034/j.1601-5215.2002.140403.x  0.18
2012 Edwards JG, Leonard BE, Hindmarch I, Curran S, Devane L. Human Psychopharmacology: The first twenty-five years Human Psychopharmacology. 27: 1-3. DOI: 10.1002/hup.1277  0.178
2006 Leonard BE. 2005–2006 prescribing guidelines (8th Edn). Edited by David Taylor, Carol Paton, Robert Kerwin. Taylor and Francis: London, 2005. ISBN 1‐84184‐500‐0 pp 383 Human Psychopharmacology-Clinical and Experimental. 21: 413-413. DOI: 10.1002/Hup.785  0.176
1986 Butler J, Leonard BE. Post-partum depression and the effect of nomifensine treatment. International Clinical Psychopharmacology. 1: 244-52. PMID 3559153  0.176
1995 Leonard BE. Current awareness in human psychopharmacology Human Psychopharmacology-Clinical and Experimental. 10: 251-258. DOI: 10.1002/Hup.470100324  0.176
1996 Leonard BE. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychotherapy and Psychosomatics. 65: 66-75. PMID 8711084  0.175
2009 Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, ... ... Leonard B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte: Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares Revista De Psiquiatria Clinica. 36: 58-76. DOI: 10.1590/S0101-60832009000800002  0.174
2011 Leonard BE. Obituary for Professor Herman Westenberg Human Psychopharmacology-Clinical and Experimental. 26: 535-535. DOI: 10.1002/Hup.1235  0.174
2009 Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, ... ... Leonard B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior Revista De Psiquiatria Clinica. 36: 17-57. DOI: 10.1590/S0101-60832009000800001  0.173
1968 Leonard BE. The effect of chronic administration of sodium barbitone on chemically and electrically induced convulsions in the rat Neuropharmacology. 7: 463-468. PMID 5712408  0.173
1982 Leonard BE. Behavioural teratology: post-natal consequences of drug exposure in utero. Archives of Toxicology. Supplement. = Archiv Fã¼R Toxikologie. Supplement. 5: 48-58. PMID 6125143  0.171
2020 Leonard B, Farrell M, Mahon M, Kinsella A, O'Donoghue C. Risky (farm) business: Perceptions of economic risk in farm succession and inheritance Journal of Rural Studies. 75: 57-69. DOI: 10.1016/J.Jrurstud.2019.12.007  0.17
1981 Leonard BE. Effect of psychotropic drugs administered to pregnant rats on the behaviour of the offspring. Neuropharmacology. 20: 1237-42. PMID 6119636  0.169
2006 Elenkov IJ, Chrousos GP, Leonard BE, Cutolo M, Straub RH, Bricou O, Taïeb O, Baubet T, Gal B, Guillevin L, Moro MR, Ball TM, Sepa A, Ludvigsson J, Bagnasco M, et al. Subject Index Vol. 13, 2006 Neuroimmunomodulation. 13: 381-382. DOI: 10.1159/000107647  0.168
1995 Leonard BE. Mirtazapine. Noradrenergic and specific serotonergic antidepressant (NaSSA). Editorial Human Psychopharmacology. 10. DOI: 10.1002/hup.470100802  0.166
1988 Butler J, Leonard BE. The platelet serotonergic system in depression and following sertraline treatment. International Clinical Psychopharmacology. 3: 343-7. PMID 3235819  0.166
1989 Leonard BE. Toxicity of antidepressants in overdose. International Journal of Clinical Pharmacology Research. 9: 101-10. PMID 2654033  0.166
1998 Leonard BE. The role of reboxetine, a selective noradrenaline reuptake inhibitor, in the treatment of depression: Introduction Human Psychopharmacology. 13: S1. DOI: 10.1002/(SICI)1099-1077(199802)13:1+3.0.CO;2-O  0.165
1997 Nsimba SED, Kelly JP, Leonard BE. Effect of chronic rafoxanide administration on behavioural and physiological parameters in the rat Indian Journal of Pharmacology. 29: 289-295.  0.165
1997 Leonard BE. Neurotransmitters in depression: noradrenaline and serotonin and their interactions. Journal of Clinical Psychopharmacology. 17: 1S. PMID 9090572  0.165
1996 Puozzo C, Leonard BE. Pharmacokinetics of milnacipran in comparison with other antidepressants. International Clinical Psychopharmacology. 11: 15-27. PMID 8923123  0.164
1982 Leonard BE. Neuropharmacology of anxiolytic drugs: A selected review of the field Drug Development Research. 2: 1-11.  0.163
1999 Leonard BE, Song C. Stress, depression, and the role of cytokines. Advances in Experimental Medicine and Biology. 461: 251-65. PMID 10442177 DOI: 10.1007/978-0-585-37970-8_14  0.163
2006 Song C, Horrobin DF, Leonard BE. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry. 39: 88-99. PMID 16721697 DOI: 10.1055/s-2006-941557  0.162
1997 Nsimba SED, Kelly JP, Leonard BE. Effect of acute and chronic haloperidol administration and apomorphine challenge on the behavioural parameters in rats Indian Journal of Pharmacology. 29: 15-19.  0.162
2013 Leonard BE. Inflammation as the cause of the metabolic syndrome in depression. Modern Trends in Pharmacopsychiatry. 28: 117-26. PMID 25224895 DOI: 10.1159/000343974  0.161
1982 Bigl V, Dalitz E, Kunert E, Biesold D, Leonard BE. The effect of d-amphetamine and amitriptyline administered to pregnant rats on the locomotor activity and neurotransmitters of the offspring. Psychopharmacology. 77: 371-5. PMID 6127748  0.161
1993 Leonard BE. In search of black bile: do antidepressants act by changing endogenous endocoids in the depressed patient? Journal of Psychopharmacology (Oxford, England). 7: 1-3. PMID 22290364 DOI: 10.1177/0269881193007001021  0.161
2010 Leonard BE, Song C. Cytokines, Stress, and Depression Encyclopedia of Stress. 705-711. DOI: 10.1016/B978-012373947-6.00111-2  0.161
1978 Lynch MA, Leonard BE. Changes in brain γ-aminobutyric acid concentrations following acute and chronic amphetamine administration and during post amphetamine depression Irish Journal of Medical Science. 147: 324-325.  0.16
2015 Leonard BE. Pain, Depression and Inflammation: Are Interconnected Causative Factors Involved? Modern Trends in Pharmacopsychiatry. 30: 22-35. PMID 26437055 DOI: 10.1159/000435930  0.16
Hide low-probability matches.